<SEC-DOCUMENT>0001213900-23-005120.txt : 20230125
<SEC-HEADER>0001213900-23-005120.hdr.sgml : 20230125
<ACCEPTANCE-DATETIME>20230125161524
ACCESSION NUMBER:		0001213900-23-005120
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230119
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230125
DATE AS OF CHANGE:		20230125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brilliant Acquisition Corp
		CENTRAL INDEX KEY:			0001787518
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39341
		FILM NUMBER:		23552634

	BUSINESS ADDRESS:	
		STREET 1:		99 DAN BA ROAD C-9
		STREET 2:		PUTUO DISTRICT
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200062
		BUSINESS PHONE:		086-021-80125497

	MAIL ADDRESS:	
		STREET 1:		99 DAN BA ROAD C-9
		STREET 2:		PUTUO DISTRICT
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200062
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea172192-8k425_brilliant.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:BRLI="http://brilliant.com/20230119">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_BRLI_brilliant.com_20230119 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20230119_20230119 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001787518 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityAddressPostalZipCode_00000 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityCentralIndexKey">0001787518</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityAddressPostalZipCode">00000</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-19to2023-01-19" id="xdx2ixbrl0016" name="dei:EntityTaxIdentificationNumber">00-0000000</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="brli-20230119.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-19to2023-01-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001787518</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-19</xbrli:startDate>
        <xbrli:endDate>2023-01-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-192023-01-19_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001787518</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRLI:UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-19</xbrli:startDate>
        <xbrli:endDate>2023-01-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-192023-01-19_custom_OrdinarySharesNoParValuePerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001787518</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRLI:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-19</xbrli:startDate>
        <xbrli:endDate>2023-01-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-192023-01-19_custom_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001787518</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRLI:RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-19</xbrli:startDate>
        <xbrli:endDate>2023-01-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-192023-01-19_custom_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001787518</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRLI:WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-19</xbrli:startDate>
        <xbrli:endDate>2023-01-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION<br />
Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_90E_edei--DocumentType_c20230119__20230119_z1GHzxVRXlI4"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF THE<br />
SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported):&#160;<b><span id="xdx_905_edei--DocumentPeriodEndDate_c20230119__20230119_zdWPCOu4svlb"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January
19, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_904_edei--EntityRegistrantName_c20230119__20230119_zAq561kWozM1"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityRegistrantName">BRILLIANT ACQUISITION CORPORATION</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20230119__20230119_zRSSok6ag1v2"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">British Virgin Islands</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityFileNumber_c20230119__20230119_zQQGF1h159pk"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityFileNumber">001-39341</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_dxL_c20230119__20230119_z0nBGs6UbF38" title="::XDX::00-0000000"><span style="-sec-ix-hidden: xdx2ixbrl0016">N/A</span></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction<br />
of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer<br />
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20230119__20230119_z1uw8buqt642" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityAddressAddressLine1">99
Dan Ba Road</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif">, <span id="xdx_906_edei--EntityAddressAddressLine2_c20230119__20230119_zst4xlAo7Al1"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityAddressAddressLine2">C-9,
Putuo District</ix:nonNumeric></span></span></b><b><span style="font-family: Times New Roman, Times, Serif">,</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_903_edei--EntityAddressCityOrTown_c20230119__20230119_zovWs8SdD1Hk" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityAddressCityOrTown">Shanghai</ix:nonNumeric></b></span><span style="font-family: Times New Roman, Times, Serif">,
<b><span id="xdx_902_edei--EntityAddressCountry_c20230119__20230119_zuqGmhsTsn07"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Peoples Republic of China</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices, including
zip code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&#8217;s telephone number, including
area code:<b>&#160;(<span id="xdx_908_edei--CityAreaCode_c20230119__20230119_zJ2nVCb3BXZ8"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:CityAreaCode">86</ix:nonNumeric></span>) <span id="xdx_904_edei--LocalPhoneNumber_c20230119__20230119_zJpBgm5hDJLk"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:LocalPhoneNumber">021-80125497</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Not Applicable<br />
</b>(Former name or former address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25px; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--WrittenCommunications_c20230119__20230119_zGTqMrWsruF7"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleantrue" name="dei:WrittenCommunications">&#9746;</ix:nonNumeric></span></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SolicitingMaterial_c20230119__20230119_z5XxeVz5I1te"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--PreCommencementTenderOffer_c20230119__20230119_zqmw87anIJ91"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20230119__20230119_zuna1O3ho8Lb"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on&#160;<br />
which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember_zEAByeqGxrql"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" name="dei:Security12bTitle">Units, each consisting of one Ordinary Share, one Right and one Redeemable Warrant</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember_z5C25Em9t4Se"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" name="dei:TradingSymbol">BRLIU</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_90B_edei--SecurityExchangeName_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember_zig8e0LuV35"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesNoParValuePerShareMember_zPBmM9simNmf"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_OrdinarySharesNoParValuePerShareMember" name="dei:Security12bTitle">Ordinary Shares, no par value per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesNoParValuePerShareMember_zf6YlagGdulj"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_OrdinarySharesNoParValuePerShareMember" name="dei:TradingSymbol">BRLI</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_905_edei--SecurityExchangeName_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesNoParValuePerShareMember_zzUZuRtppc0g"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_OrdinarySharesNoParValuePerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember_zl9I9N9B0xL7"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" name="dei:Security12bTitle">Rights, each right entitling the holder to 1/10 of one Ordinary Share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--TradingSymbol_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember_zRGrUcD4eAOe"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" name="dei:TradingSymbol">BRLIR</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_902_edei--SecurityExchangeName_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember_zuFX20jMdSEg"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember_zgoDyCrKsyD1"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" name="dei:Security12bTitle">Warrants, each warrant exercisable for one Ordinary Share for $11.50 per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--TradingSymbol_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember_zAa7Vi9snh"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" name="dei:TradingSymbol">BRLIW</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_902_edei--SecurityExchangeName_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember_z2OUw9zovxMa"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company&#160;<span id="xdx_906_edei--EntityEmergingGrowthCompany_c20230119__20230119_z6ZgHBiDA2xd"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span id="xdx_90B_edei--EntityExTransitionPeriod_c20230119__20230119_zsmHETebUMAh"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry into a Material definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Amendment to Merger Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously reported, on February 22, 2022,
Brilliant Acquisition Corporation, a British Virgin Islands company (&#8220;Brilliant&#8221;), entered into an Agreement and Plan of Merger
(as it may be amended, supplemented or otherwise modified from time to time, the &#8220;Merger Agreement&#8221;), by and among Brilliant
and Nukkleus Inc., a Delaware corporation (&#8220;Nukkleus&#8221;). Upon consummation of the transactions contemplated by the Merger Agreement,
Nukkleus would become a Nasdaq-listed company (&#8220;PubCo&#8221;) and the parent company of Brilliant. The transactions contemplated
by the Merger Agreement, are hereinafter referred to as the &#8220;Business Combination.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 20, 2023, parties to the Merger Agreement
entered into an Amendment No. 3 to the Merger Agreement (the &#8220;Amendment&#8221;) solely to extend the Outside Closing Date (as defined
in the Merger Agreement), to the later of (i) April 23, 2023, or, (ii) following the approval by Brilliant&#8217;s shareholders of an
extension of the life of the SPAC pursuant to Brilliant&#8217;s organizational documents, to the date so approved, but not later than
June 23, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing descriptions of the Merger Agreement
and the Amendment are not complete and are subject to and qualified in their entirety by reference to the Merger Agreement and the Amendment,
copies of which are filed with this Current Report on Form 8-K as Exhibits 2.1 and 2.2, respectively, and the terms of which are incorporated
by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Promissory Note</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The disclosure contained in Item 2.03 is incorporated by reference
in this Item 1.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 2.03 Creation of a Direct Financial Obligation
or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brilliant issued an unsecured promissory note
dated January 20, 2023, in the aggregate principal amount of $21,350 (the &#8220;Note&#8221;) to Nukkleus. The Note does not bear interest
and matures upon closing of the Company&#8217;s initial business combination. In the event that the Company does not consummate a business
combination, the Note will be repaid only from amounts remaining outside of the Company&#8217;s trust account, if any. The proceeds of
the Note have been deposited in the Company&#8217;s trust account in connection with extending the business combination completion window
until February 23, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Note is qualified
in its entirety by reference to the full text of the Note, a copy of which is filed with this Current Report on Form 8-K as Exhibit 10.1
and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.03. Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 23, 2023, subsequent to the approval
by its shareholders of the amended and restated articles of association (the &#8220;Amended Articles&#8221;) of the Company, the Company
filed the Amended Articles with the British Virgin Islands General Registry, effective the same day. The Amended Articles extend the date
by which the Company has to consummate a business combination from January 23, 2023 to up to not later than April 23, 2023, extendable
by the Company on a monthly basis without further shareholder approval upon deposit of $0.04 per public ordinary share of the Company
(the &#8220;Top-up Amount&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Notwithstanding
the Top-up Amount set forth in the Amended Articles, as disclosed in the Definitive Additional Materials on Form <a href="http://www.sec.gov/Archives/edgar/data/1787518/000121390023002978/ea171783-defa14a_brilliant.htm">DEFA14A</a></span>&#160;
<span style="font-family: Times New Roman, Times, Serif">filed by the Company with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
on January 17, 2023, the Company undertook to increase the amount to be paid into the Trust Account for each monthly extension from $0.04
to $0.0525. Subsequently, the Company has committed to increase the amount to be paid into the Trust Account for any extension from February
23, 2023 to March 23, 2023 and from March 23, 2023 April 23, 2023 to $0.08 per ordinary share outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.07. Submissions of Matters to a Vote
of Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company held the special meeting of shareholders
of the Company (the &#8220;Special Meeting&#8221;) on January 19, 2023 at 10:00 a.m. Eastern Time. The Special Meeting was held via teleconference.
Summarized below are the results of the matters submitted to a vote at the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Matter</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Against</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Abstain</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -9pt; padding-left: 9pt">Proposal 1 &#8211; The Extension Amendment Proposal - A proposal to amend the Company&#8217;s currently adopted amended and restated articles of association (the &#8220;Current Articles&#8221;), to extend the date by which the Company has to consummate a business combination from January 23, 2023 to up to not later than April 23, 2023 by deleting articles 18.6(A) and 18(B) of the Current Articles in their entirety, and replacing them with new articles 18.6(A) and 18.6(B), respectively, as set forth in Annex A to the Company&#8217;s proxy statement.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,630,091</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">30</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Proposal 2 &#8211; The Amended Articles Proposal - A proposal to adopt an amended and restated articles of association of the Company reflecting the amendments to the Current Articles set out in Proposal 1.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,630,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Proposal 1 and Proposal 2 were approved by the
Company&#8217;s shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 7.01 Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s shareholders elected to redeem
an aggregate of 159,203 shares in connection with the Special Meeting. Following such redemptions and the deposit of the contribution
described above, the amount of funds remaining in the trust account is approximately $4.4 million. Accordingly, following such redemptions
and the deposit of the contribution of $0.525 per outstanding ordinary share, the Company has 1,816,733 ordinary shares issued and outstanding
(1,411,000 of which are shares held by our initial shareholders and are not subject to redemption) and the pro rata portion of the funds
available in the trust account is approximately $10.77 per public share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 24, 2023, the Company issued a press
release, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K, announcing that the Company has extended the
period of time it will have to consummate its initial business combination by a further one month, or until February 23, 2023, and related
matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in this Item 7.01, including Exhibit
99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Additional Information
and Where to Find It</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This Current Report relates
to a proposed business combination among Nukkleus, Brilliant and Merger Sub in which Merger Sub would merge into Brilliant. In connection
with the proposed transaction, Nukkleus has filed with the SEC a registration statement on Form S-4 that includes a proxy statement of
Nukkleus and that also constitutes a prospectus of Nukkleus with respect to the PubCo Shares to be issued in the proposed transaction
(the &#8220;proxy statement/prospectus&#8221;). The definitive proxy statement/prospectus (if and when available) will be delivered to
Nukkleus&#8217;s stockholders. Each of Nukkleus and Brilliant may also file other relevant documents regarding the proposed transaction
with the SEC. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND SECURITY HOLDERS OF NUKKLEUS AND BRILLIANT ARE URGED TO READ
THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS THAT ARE FILED WITH THE SEC IN CONNECTION WITH
THE PROPOSED TRANSACTION, INCLUDING ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL
CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Investors and security
holders may obtain free copies of the proxy statement/prospectus (if and when available) and other documents that are filed or will be
filed with the SEC by Brilliant or Nukkleus through the website maintained by the SEC at www.sec.gov. Stockholders of Nukkleus will also
be able to obtain a copy of the definitive proxy statement, without charge by directing a request to: Nukkleus, Inc., 525 Washington Boulevard,
Jersey City, New Jersey 07310. Shareholders of Brilliant will also be able to obtain a copy of the definitive proxy statement, without
charge by directing a request to: Brilliant Acquisition Corporation, 99 Dan Ba Road, C-9, Putuo District, Shanghai, Peoples Republic of
China.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Participants in the
Solicitation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Brilliant and its directors
and executive officers are participants in the solicitation of proxies from the shareholders of Brilliant in respect of the proposed transaction.
Information about Brilliant&#8217;s directors and executive officers and their ownership of Brilliant&#8217;s ordinary shares is set forth
in Brilliant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 31, 2022. Other information
regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or
otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC in respect of the
proposed transaction when they become available. You may obtain free copies of these documents as described in the preceding paragraph.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Nukkleus and its directors
and executive officers are participants in the solicitation of proxies from the shareholders of Nukkleus in respect of the proposed transaction.
Information about Nukkleus&#8217;s directors and executive officers and their ownership of Nukkleus common stock is set forth in Nukkleus&#8217;s
Annual Report on Form 10-K for the year ended September 30, 2021, initially filed with the SEC on December 29, 2021, as amended to date.
Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security
holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC in respect
of the proposed transaction when they become available. You may obtain free copies of these documents as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Cautionary Note Regarding
Forward-Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Forward-looking statements
are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a
result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking
statements in this document, including but not limited to: (i) the risk that the proposed business combination may not be completed in
a timely manner or at all, which may adversely affect the price of Nukkleus and/or Brilliant securities; (ii) the risk that the proposed
business combination may not be completed by Brilliant&#8217;s business combination deadline and the potential failure to obtain an extension
of the business combination deadline if sought by Brilliant; (iii) the failure to satisfy the conditions to the consummation of the proposed
business combination, including the approval of the proposed business combination by the stockholders of Nukkleus and/or Brilliant, the
satisfaction of the minimum trust account amount following redemptions by Brilliant&#8217;s public shareholders and the receipt of certain
governmental and regulatory approvals; (iv) the effect of the announcement or pendency of the proposed business combination on Nukkleus&#8217;s
business relationships, performance, and business generally; (v) risks that the proposed business combination disrupts current plans of
Nukkleus and potential difficulties in Nukkleus employee retention as a result of the proposed business combination; (vi) the outcome
of any legal proceedings that may be instituted against Nukkleus or Brilliant related to the agreement and plan of merger or the proposed
business combination; (vii) the ability to maintain the listing of Brilliant&#8217;s securities on the Nasdaq Stock Market; (viii) the
price of Nukkleus&#8217;s and/or Brilliant&#8217;s securities, including volatility resulting from changes in the competitive and highly
regulated industries in which Nukkleus and Brilliant plan to operate, variations in performance across competitors, changes in laws and
regulations affecting Nukkleus&#8217;s business and changes in the combined capital structure; and (ix) the ability to implement business
plans, forecasts, and other expectations after the completion of the proposed business combination, and identify and realize additional
opportunities. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks
and uncertainties described in the proxy statement/prospectus contained in Nukkleus&#8217;s Form S-4 registration statement described
below, including those under &#8220;Risk Factors&#8221; therein, the Annual Report on Form 10-K for Nukkleus and Brilliant, Quarterly
Reports on Form 10-Q for Nukkleus and Brilliant and other documents filed by Nukkleus and/or Brilliant from time to time with the U.S.
Securities and Exchange Commission (the &#8220;SEC&#8221;). These filings identify and address other important risks and uncertainties
that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking
statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and
Nukkleus and Brilliant assume no obligation and, except as required by law, do not intend to update or revise these forward-looking statements,
whether as a result of new information, future events, or otherwise. Neither Nukkleus nor Brilliant gives any assurance that either Nukkleus
or Brilliant will achieve its expectations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>No Offer or Solicitation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This communication is
not intended to and will not constitute an offer to sell or the solicitation of an offer to sell or to buy any securities or a solicitation
of any vote or approval and is not a substitute for the proxy statement/prospectus or any other document that Brilliant or Nukkleus may
file with the SEC or send to Nukkleus&#8217;s and/or Brilliant&#8217;s shareholders in connection with the proposed transaction. No offer
of securities will be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c) Exhibits:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit No.</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&#8224;</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1787518/000121390022008813/ea155992ex2-1_brilliantacq.htm" style="-sec-extract: exhibit">Agreement and Plan of Merger, dated as of February 22, 2022, by and among Nukkleus Inc. and Brilliant Acquisition Corporation (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 23, 2022).</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea172192ex2-2_brilliant.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment No 3. to Agreement and Plan of Merger, dated as of January 20, 2023, by and among Nukkleus Inc. and Brilliant Acquisition Corporation.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea172192ex3-1_brilliant.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Articles of Association</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea172192ex10-1_brilliant.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory Note, dated January 20, 2023</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea172192ex99-1_brilliant.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated January 24, 2023</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.75in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">&#8224;</td><td style="text-align: justify">Certain of the exhibits and schedules to this exhibit have been
omitted in accordance with Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of all omitted exhibits
and schedules to the SEC upon its request.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BRILLIANT ACQUISITION CORPORATION</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Dr. Peng Jiang</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160; </span></td>
    <td style="width: 31%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Peng Jiang</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: January 25, 2023</span></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">6</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>









</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>2
<FILENAME>ea172192ex2-2_brilliant.htm
<DESCRIPTION>AMENDMENT NO 3. TO AGREEMENT AND PLAN OF MERGER, DATED AS OF JANUARY 20, 2023, BY AND AMONG NUKKLEUS INC. AND BRILLIANT ACQUISITION CORPORATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 2.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENT NO. 3 TO AGREEMENT AND PLAN OF MERGER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">January <U>20</U>, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS AMENDMENT NO.&nbsp;3
to the Agreement and Plan of Merger (as amended prior to the date hereof, the &#8220;<U>Merger Agreement</U>&#8221;), dated as of February
22, 2022, by and among Nukkleus Inc., a Delaware corporation (the &#8220;<U>Company</U>&#8221;), Brilliant Acquisition Corporation, a
British Virgin Islands company (the &#8220;<U>SPAC</U>&#8221;) and NB Merger Sub, Inc., a British Virgin Islands company, is effective
as of this <U>20th</U> day of January, 2023 (this &#8220;<U>Amendment</U>&#8221;). Capitalized terms used herein but not defined herein
shall have the meanings ascribed to them in the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the mutual
promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">1.   <B>Amendment.</B>
The first sentence of Section&nbsp;12.1(a) of the Merger Agreement is hereby amended as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(a)    In
the event that the Closing of the transactions contemplated hereunder has not occurred by the later of (i)&nbsp;April 23, 2023, or, (ii)&nbsp;following
the approval by the SPAC shareholders of the extension of the life of the SPAC pursuant to the SPAC&#8217;s Organizational Documents,
to the date so approved, but not later than June&nbsp;23, 2023 (such later date, the &#8220;<U>Outside Closing Date</U>&#8221;), and no
material breach of this Agreement by the party seeking to terminate this Agreement shall have occurred or have been made (as provided
in Section 12.2 hereof), the SPAC or the Company, as the case may be, shall have the right, at its sole option, to terminate this Agreement
without liability to the other side.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">2.   <B>No
Other Amendments, etc. </B>Except as provided in this Amendment, the Merger Agreement shall remain unmodified and in full force and effect,
and the execution of this Amendment is not a waiver by the Company or the SPAC of any of the terms or provisions of the Merger Agreement
and each party reserves any and all other rights and remedies available to it under the Merger Agreement. All reference in and to the
Merger Agreement (including any annexes, exhibits or schedules thereto) shall be deemed to be references to the Merger Agreement as amended
by this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">3.   <B>Governing
Law</B>. This Amendment and the legal relations among the Parties with respect to this Amendment will be governed by and construed in
accordance with the provisions contained in <U>Section&nbsp;13.7</U> of the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">4.   <B>Counterparts.
</B>This Amendment may be executed by signatures exchanged via facsimile or other electronic means and in one or more counterparts, each
of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">IN WITNESS WHEREOF, the parties hereto have caused
this Amendment to be duly executed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BRILLIANT ACQUISITION CORPORATION </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Peng Jiang</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Peng Jiang</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: CEO</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<FONT STYLE="font-variant: small-caps">Signature Page to Amendment
No. 3 to Merger Agreement</FONT>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Amendment to be duly executed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NUKKLEUS INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Emil Assentato</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Emil Assentato</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">[<FONT STYLE="font-variant: small-caps">Signature Page to Amendment
No. 3 to Merger Agreement</FONT>]</P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>ea172192ex3-1_brilliant.htm
<DESCRIPTION>AMENDED AND RESTATED ARTICLES OF ASSOCIATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">TERRITORY OF THE
BRITISH VIRGIN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ISLANDS THE BVI BUSINESS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">COMPANIES ACT, 2004 AMENDED AND</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">RESTATED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLES OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ASSOCIATION
OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Brilliant Acquisition
Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">A COMPANY LIMITED
BY SHARES</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Amended and restated
by a Resolution of Members passed on 19 January 2023 and filed on 23 January 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.5pt; text-align: center; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">REGISTERED SHARES</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">1.1.</TD><TD STYLE="text-align: justify">Every Member is entitled to a certificate signed by a director of the Company or under the Seal specifying
the number of Shares held by him and the signature of a Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">1.2.</TD><TD STYLE="text-align: justify">Any Member receiving a certificate shall indemnify and hold the Company and its Directors and officers
harmless from any loss or liability which it or they may incur by reason of any wrongful or fraudulent use or representation made by any
person by virtue of the possession thereof. If a certificate for Shares is worn out or lost it may be renewed on production of the worn
out certificate or on satisfactory proof of its loss together with such indemnity as may be required by a Resolution of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">1.3.</TD><TD STYLE="text-align: justify">If several Eligible Persons are registered as joint holders of any Shares, any one of such Eligible Persons
may give an effectual receipt for any Distribution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">SHARES</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.1.</TD><TD STYLE="text-align: justify">Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company
in general meeting), the Act and, where applicable, the rules of the Designated Stock Exchange and/or any competent regulatory authority,
and without prejudice to any rights attached to any existing Shares, the Directors may allot, issue, grant options over or otherwise dispose
of Shares (including fractions of a Share) with or without preferred, deferred or other rights or restrictions, whether in regard to Dividend
or other distribution, voting, return of capital or otherwise and to such persons, at such times and on such other terms as they think
proper, and may also (subject to the Act and the Articles) vary such rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.2.</TD><TD STYLE="text-align: justify">The Company may issue Securities to Eligible Persons conferring the right upon the holders thereof to
subscribe for, purchase or receive any class of Shares or other securities in the Company on such terms as the Directors may from time
to time determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.3.</TD><TD STYLE="text-align: justify">Section 46 of the Act does not apply to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.4.</TD><TD STYLE="text-align: justify">The Company may issue units of Securities in the Company, which may be comprised of whole or fractional
Shares, rights, options, warrants or convertible securities or securities of similar nature conferring the right upon the holders thereof
to subscribe for, purchase or receive any class of Shares or other Securities in the Company, upon such terms as the Directors may from
time to time determine. The Securities comprising any such units which are issued pursuant to the IPO can only be traded separately from
one another on the 90th day following the date of the prospectus relating to the IPO unless the representative of the Underwriters in
the IPO determines that an earlier date is acceptable, subject to the Company having filed a current report on Form 8-K with the SEC and
a press release announcing when such separate trading will begin. Prior to such date, the units can be traded, but the securities comprising
such units cannot be traded separately from one another.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.5.</TD><TD STYLE="text-align: justify">No Shares may be issued for a consideration other than money, unless a Resolution of Directors has been
passed stating:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">the amount to be credited for the issue of the Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">their determination of the reasonable present cash value of the non-money consideration for the issue;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">that, in their opinion, the present cash value of the non-money consideration for the issue is not less
than the amount to be credited for the issue of the Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.6.</TD><TD STYLE="text-align: justify">The Company shall keep a Register of Members, in compliance with section 41 of the Act, containing:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">the names and addresses of the persons who hold Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">the number of each class and series of Shares held by each Member;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">the date on which the name of each Member was entered in the Register of Members; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">the date on which any Eligible Person ceased to be a Member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.7.</TD><TD STYLE="text-align: justify">The Register of Members may be in any such form as the Directors may approve, but if it is in magnetic,
electronic or other data storage form, the Company must be able to produce legible evidence of its contents. Until the Directors otherwise
determine, the magnetic, electronic or other data storage form shall be the original share register.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.8.</TD><TD STYLE="text-align: justify">A Share is deemed to be issued when the name of the Member is entered in the Register of Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">FORFEITURE</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">3.1.</TD><TD STYLE="text-align: justify">Shares that are not fully paid on issue are subject to the forfeiture provisions set forth in this Regulation
and for this purpose Shares and Securities issued for a promissory note or a contract for future services are deemed to be not fully paid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">3.2.</TD><TD STYLE="text-align: justify">A written notice (&ldquo;<B>Call Notice</B>&rdquo;) of call specifying the date for payment to be made
shall be served on the Member who defaults in making payment in respect of the Shares and Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">3.3.</TD><TD STYLE="text-align: justify">The Call Notice referred to in Regulation 3.2 shall name a further date not earlier than the expiration
of 14 days from the date of service of the Call Notice on or before which the payment required by the Call Notice is to be made and shall
contain a statement that in the event of non-payment at or before the time named in the Call Notice, the Shares or Securities, or any
of them, in respect of which payment is not made will be liable to be forfeited.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">3.4.</TD><TD STYLE="text-align: justify">Where a Call Notice has been issued pursuant to Regulation 3.2 and the requirements of the Call Notice
have not been complied with, the Directors may, at any time before tender of payment, forfeit and cancel the Shares and Securities to
which the Call Notice relates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">3.5.</TD><TD STYLE="text-align: justify">The Company is under no obligation to refund any moneys to the Member whose Shares or Securities have
been cancelled pursuant to Regulation 3.4 and that Member shall be discharged from any further obligation to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">TRANSFER OF SHARES</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">4.1.</TD><TD STYLE="text-align: justify">Subject to the Memorandum shares may be transferred by a written instrument of transfer signed by the
transferor and containing the name and address of the transferee, which shall be sent to the Company for registration, provided that such
transfer also complies with applicable rules of the SEC and federal and state securities laws of the United States. If the Shares in question
were issued in conjunction with rights, options or warrants issued on terms that one cannot be transferred without the other, the Directors
shall refuse to register the transfer of any such Share without evidence satisfactory to them of the like transfer of such option or warrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">4.2.</TD><TD STYLE="text-align: justify">Shares held by the Founders shall not be transferred (except (1) to any persons (including their affiliates
and shareholders) participating in the private placement of the private units, officers, directors, shareholders, employees and members
of the Sponsor and its affiliates, (2)&nbsp;amongst initial holders or to the Company&rsquo;s officers, directors and employees, (3) if
a holder is an entity, as a distribution to its partners, shareholders or members upon its liquidation, (4) by bona fide gift to a member
of the holder&rsquo;s immediate family or to a trust, the beneficiary of which is a holder or a member of a holder&rsquo;s immediate family,
for estate planning purposes, (5) by virtue of the laws of descent and distribution upon death, (6) pursuant to a qualified domestic relations
order, (7) by certain pledges to secure obligations incurred in connection with purchases of the Company&rsquo;s securities, (8) by private
sales at prices no greater than the price at which the applicable securities were originally purchased or (9) to the Company for no value
for cancellation in connection with the consummation of the Company&rsquo;s initial Business Combination, in each case (except for clause
9) where the transferee agrees to the terms of the insider letter and by the same agreements entered into by the Sponsor with respect
to such securities (including provisions relating to voting, the trust account and liquidation distributions described in the prospectus
issued by the Company in respect of the IPO))) until the earlier of (i) one year after the date of the consummation of the initial Business
Combination; or (ii) the date on which the closing price of the Ordinary Shares equals or exceeds $12.50 per share (as adjusted for share
splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period following the
six month anniversary of the consummation of our initial Business Combination, or earlier, in either case, if, subsequent to the initial
Business Combination, the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction which results
in all of the Members having the right to exchange their Ordinary Shares for cash, securities or other property.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">4.3.</TD><TD STYLE="text-align: justify">In addition to the above, the instrument of transfer of any Share shall be in writing in the usual or
common form or in a form prescribed by the Designated Stock Exchange or in any other form approved by the officers of the Company and
shall be executed by or on behalf of the transferor (and if the Directors so require, signed by or on behalf of the transferee) and may
be under hand or, if the transferor or transferee is a clearing house or its nominee(s), by hand or by machine imprinted signature or
by such other manner of execution as the Directors may approve from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">4.4.</TD><TD STYLE="text-align: justify">The transfer of a Share is effective when the name of the transferee is entered on the share register.
The transferor shall be deemed to remain the holder of a Share until the name of the transferee is entered in the Register of Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">4.5.</TD><TD STYLE="text-align: justify">If the Directors of the Company are satisfied that an instrument of transfer relating to Shares has been
signed but that the instrument has been lost or destroyed, they may resolve by Resolution of Directors:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">to accept such evidence of the transfer of Shares as they consider appropriate; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">that the transferee&rsquo;s name should be entered in the Register of Members notwithstanding the absence
of the instrument of transfer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">4.6.</TD><TD STYLE="text-align: justify">Subject to the Memorandum, the personal representative of a deceased Member may transfer a Share even
though the personal representative is not a Member at the time of the transfer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">DISTRIBUTIONS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">5.1.</TD><TD STYLE="text-align: justify">The Company may by Resolution of Directors, authorize a distribution at a time and of an amount they think
fit if they are satisfied, on reasonable grounds, that, immediately after the distribution, the value of the Company&rsquo;s assets will
exceed its liabilities and the Company will be able to pay its debts as and when they fall due.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">5.2.</TD><TD STYLE="text-align: justify">Dividends may be paid in money, shares, or other property.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">5.3.</TD><TD STYLE="text-align: justify">The Company may, by Resolution of Directors, from time to time pay to the Members such interim dividends
as appear to the Directors to be justified by the profits of the Company, provided always that they are satisfied, on reasonable grounds,
that, immediately after the distribution, the value of the Company&rsquo;s assets will exceed its liabilities and the Company will be
able to pay its debts as and when they fall due.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">5.4.</TD><TD STYLE="text-align: justify">Notice in writing of any dividend that may have been declared shall be given to each Member in accordance
with Regulation 20 and all dividends unclaimed for three years after such notice has been given to a Member may be forfeited by Resolution
of Directors for the benefit of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">5.5.</TD><TD STYLE="text-align: justify">No dividend shall bear interest as against the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">REDEMPTION OF SHARES AND TREASURY SHARES</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.1.</TD><TD STYLE="text-align: justify">Subject to these Articles, the Company may purchase, redeem or otherwise acquire and hold its own Shares
save that the Company may not purchase, redeem or otherwise acquire its own Shares without the consent of the Member whose Shares are
to be purchased, redeemed or otherwise acquired unless the Company is permitted by the Act or any other provision in the Memorandum or
Articles to purchase, redeem or otherwise acquire the Shares without such consent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.2.</TD><TD STYLE="text-align: justify">The purchase redemption or other acquisition by the Company of its own Shares is deemed not to be a distribution
where:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">The Company purchases, redeems or otherwise acquires the Shares pursuant to a right of a Member to have
his Shares redeemed or to have his shares exchanged for money or other property of the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">The Company purchases, redeems or otherwise acquires the Shares by virtue of the provisions of section
176of the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.3.</TD><TD STYLE="text-align: justify">Sections 60, 61 and 62 of the Act shall not apply to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.55pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.4.</TD><TD STYLE="text-align: justify">Shares that the Company purchases, redeems or otherwise acquires pursuant to this Regulation may be cancelled
or held as Treasury Shares except to the extent that such Shares are in excess of 50 percent of the issued Shares in which case they shall
be cancelled but they shall be available for reissue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.5.</TD><TD STYLE="text-align: justify">All rights and obligations attaching to a Treasury Share are suspended and shall not be exercised by the
Company while it holds the Share as a Treasury Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.6.</TD><TD STYLE="text-align: justify">Treasury Shares may be disposed of by the Company on such terms and conditions (not otherwise inconsistent
with the Memorandum and Articles) as the Company may by Resolution of Directors determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.7.</TD><TD STYLE="text-align: justify">Where Shares are held by another body corporate of which the Company holds, directly or indirectly, shares
having more than 50 per cent of the votes in the election of directors of the other body corporate, all rights and obligations attaching
to the Shares held by the other body corporate are suspended and shall not be exercised by the other body corporate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">MEETINGS AND CONSENTS OF MEMBERS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.1.</TD><TD STYLE="text-align: justify">Any director of the Company may convene meetings of the Members at such times and in such manner and places
within or outside the British Virgin Islands as the director considers necessary or desirable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.2.</TD><TD STYLE="text-align: justify">Upon the written request of the Members entitled to exercise thirty per cent (30%) or more of the voting
rights in respect of the matter for which the meeting is requested the Directors shall convene a meeting of Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.3.</TD><TD STYLE="text-align: justify">The Director convening a meeting shall give at least ten (10) days&rsquo; written notice of a meeting
of Members to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">those Members whose names on the date the notice is given appear as Members in the Register of Members
and are entitled to vote at the meeting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">the other Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.4.</TD><TD STYLE="text-align: justify">The director convening a meeting of Members may fix as the record date for determining those Members that
are entitled to vote at the meeting the date notice is given of the meeting, or such other date as may be specified in the notice, being
a date not earlier than the date of the notice.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.5.</TD><TD STYLE="text-align: justify">A meeting of Members held in contravention of the requirement to give notice is valid if Members holding
at least 90 per cent of the total voting rights on all the matters to be considered at the meeting have waived notice of the meeting and,
for this purpose, the presence of a Member at the meeting shall constitute waiver in relation to all the Shares which that Member holds.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.6.</TD><TD STYLE="text-align: justify">The inadvertent failure of a director who convenes a meeting to give notice of a meeting to a Member or
another director, or the fact that a Member or another director has not received notice, does not invalidate the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.7.</TD><TD STYLE="text-align: justify">A Member may be represented at a meeting of Members by a proxy who may speak and vote on behalf of the
Member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.8.</TD><TD STYLE="text-align: justify">The instrument appointing a proxy shall be produced at the place designated for the meeting before the
time for holding the meeting at which the person named in such instrument proposes to vote.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.9.</TD><TD STYLE="text-align: justify">The instrument appointing a proxy shall be in substantially the following form or such other form as the
chairman of the meeting shall accept as properly evidencing the wishes of the Member appointing the proxy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt; border-left: Black 1.5pt solid; border-right: Black 1.5pt solid; border-top: Black 1.5pt solid; text-indent: 0in; font-size: 10pt; padding-left: 2pt"><B><I>To: [&#9679;]</I></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt; border-left: Black 1.5pt solid; border-right: Black 1.5pt solid; text-indent: 0in; font-size: 10pt; padding-left: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2pt; text-align: justify; border-left: Black 1.5pt solid; border-right: Black 1.5pt solid; padding-right: 2pt; text-indent: 0in; font-size: 10pt"><I>I/We, being a Member of the above Company HEREBY APPOINT ...................... of ..............................or failing him ................ of ................................. to be my/our proxy to vote for me/us at the meeting of Members to be held on the ............... day of ....., 20.... and at any adjournment thereof.</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2pt; text-align: justify; border-left: Black 1.5pt solid; border-right: Black 1.5pt solid; padding-right: 2pt; text-indent: 0in; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2pt; border-left: Black 1.5pt solid; border-right: Black 1.5pt solid; padding-right: 2pt; text-indent: 0in; font-size: 10pt"><I>(Any restrictions on voting to be inserted here.) Signed this ...... day of ............., 20....</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt; border-left: Black 1.5pt solid; border-right: Black 1.5pt solid; text-indent: 0in; font-size: 10pt; padding-left: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt; border-left: Black 1.5pt solid; border-right: Black 1.5pt solid; text-indent: 0in; font-size: 10pt; padding-left: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt; border-left: Black 1.5pt solid; border-right: Black 1.5pt solid; text-indent: 0in; font-size: 10pt; padding-left: 2pt"><I>.............................................</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2pt; border-left: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-right: Black 1.5pt solid; text-indent: 0in; font-size: 10pt; padding-left: 2pt"><I>Member</I></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.10.</TD><TD STYLE="text-align: justify">The following applies where Shares are jointly owned:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">if two or more persons hold Shares jointly each of them may be present in person or by proxy at a meeting
of Members and may speak as a Member;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">if only one of the joint owners is present in person or by proxy he may vote on behalf of all joint owners;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">if two or more of the joint owners are present in person or by proxy they must vote as one and in the
event of disagreement between any of the joint owners of Shares then the vote of the joint owner whose name appears first (or earliest)
in the Register of Members in respect of the relevant Shares shall be recorded as the vote attributable to the Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.11.</TD><TD STYLE="text-align: justify">A Member shall be deemed to be present at a meeting of Members if he participates by telephone or other
electronic means and all Members participating in the meeting are able to hear each other.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.12.</TD><TD STYLE="text-align: justify">A meeting of Members is duly constituted if, at the commencement of the meeting, there are present in
person or by proxy Members representing not less than thirty per cent (30%) of the votes of the Shares entitled to vote on Resolutions
of Members to be considered at the meeting. If the Company has two or more classes of shares, a meeting may be quorate for some purposes
and not for others. A quorum may comprise a single Member or proxy and then such person may pass a Resolution of Members and a certificate
signed by such person accompanied where such person holds a proxy by a copy of the proxy instrument shall constitute a valid Resolution
of Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.13.</TD><TD STYLE="text-align: justify">If within two hours from the time appointed for the meeting a quorum is not present, the meeting, if convened
upon the requisition of Members, shall be dissolved; in any other case it shall stand adjourned to the next business day in the jurisdiction
in which the meeting was to have been held at the same time and place, and if at the adjourned meeting there are present within one hour
from the time appointed for the meeting in person or by proxy not less than one third of the votes of the Shares or each class or series
of Shares entitled to vote on the matters to be considered by the meeting, those present shall constitute a quorum but otherwise the meeting
shall be dissolved.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.14.</TD><TD STYLE="text-align: justify">At every meeting of Members, the chairman of the Board shall preside as chairman of the meeting. If there
is no chairman of the Board or if the chairman of the Board is not present at the meeting, the Members present shall choose one of their
number to be the chairman. If the Members are unable to choose a chairman for any reason, then the person representing the greatest number
of voting Shares present in person or by proxy at the meeting shall preside as chairman failing which the oldest individual Member or
representative of a Member present shall take the chair.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.15.</TD><TD STYLE="text-align: justify">The chairman may, with the consent of the meeting, adjourn any meeting from time to time, and from place
to place.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.16.</TD><TD STYLE="text-align: justify">At any meeting of the Members the chairman is responsible for deciding in such manner as he considers
appropriate whether any resolution proposed has been carried or not and the result of his decision shall be announced to the meeting and
recorded in the minutes of the meeting. If the chairman has any doubt as to the outcome of the vote on a proposed resolution, he shall
cause a poll to be taken of all votes cast upon such resolution. If the chairman fails to take a poll then any Member present in person
or by proxy who disputes the announcement by the chairman of the result of any vote may immediately following such announcement demand
that a poll be taken and the chairman shall cause a poll to be taken. If a poll is taken at any meeting, the result shall be announced
to the meeting and recorded in the minutes of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.17.</TD><TD STYLE="text-align: justify">Subject to the specific provisions contained in this Regulation for the appointment of representatives
of Members other than individuals the right of any individual to speak for or represent a Member shall be determined by the law of the
jurisdiction where, and by the documents by which, the Member is constituted or derives its existence. In case of doubt, the Directors
may in good faith seek legal advice and unless and until a court of competent jurisdiction shall otherwise rule, the Directors may rely
and act upon such advice without incurring any liability to any Member or the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.18.</TD><TD STYLE="text-align: justify">Any Member, other than an individual, may by resolution of its directors or other governing body, authorize
such individual as it thinks fit to act as its representative at any meeting of Members or of any class of Members, and the individual
so authorized shall be entitled to exercise the same rights on behalf of the Member which he represents as that Member could exercise
if it were an individual.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.19.</TD><TD STYLE="text-align: justify">The chairman of any meeting at which a vote is cast by proxy or on behalf of any Member other than an
individual may at the meeting but not thereafter call for a notarially certified copy of such proxy or authority which shall be produced
within 7 days of being so requested or the votes cast by such proxy or on behalf of such Member shall be disregarded.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.20.</TD><TD STYLE="text-align: justify">Directors of the Company may attend and speak at any meeting of Members and at any separate meeting of
the holders of any class or series of Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">7.21.</TD><TD STYLE="text-align: justify">An action that may be taken by the Members at a meeting may also be taken by a Resolution of Members consented
to in writing, without the need for any prior notice. If any Resolution of Members is adopted otherwise than by the unanimous written
consent of all Members, a copy of such resolution shall forthwith be sent to all Members not consenting to, or not having signed, such
resolution. The consent may be in the form of counterparts, each counterpart being signed by one or more Members. If the consent is in
one or more counterparts, and the counterparts bear different dates, then the resolution shall take effect on the earliest date upon which
Eligible Persons holding a sufficient number of votes of Shares to constitute a Resolution of Members have consented to the resolution
by signed counterparts.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">UNTRACEABLE MEMBERS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">8.1.</TD><TD STYLE="text-align: justify">Where any Member is untraceable, the Company may sell any of their Shares provided that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">no less than 3 checks for any sums payable in cash to such Member have remained uncashed for a period
of 12 years from the date of issue of the check;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">the Company not having during that time or before the expiry of the three-month period referred to in
(c) below received any indication of the existence of the Member or person entitled to such shares by death, bankruptcy or operation of
law; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">upon expiration of the 12-year period, an advertisement has been published in newspapers, giving notice
of the Company&rsquo;s intention to sell those Shares, and a period of three months or such shorter period has elapsed since the date
of such advertisement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.3pt; text-align: justify; text-indent: 0in">then, the net proceeds
of any such sale shall be held in the Company, and the net proceeds shall be accounted as a debt due to that untraceable Member for an
amount equal to such net proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.3pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify">DIRECTORS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.1.</TD><TD STYLE="text-align: justify">The Director or Directors shall be elected by Resolution of Members or by Resolution of Directors for
such term as the Members or Directors shall determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.2.</TD><TD STYLE="text-align: justify">No person shall be appointed as a director of the Company unless he has consented in writing to act as
a director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.3.</TD><TD STYLE="text-align: justify">Subject to Regulation 9.1, the minimum number of Directors shall be one (1) and there shall be no maximum
number of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.4.</TD><TD STYLE="text-align: justify">Each Director holds office for the term, if any, fixed by the Resolution of Members or Resolution of Directors
appointing him, or until his earlier death, resignation or removal. If no term is fixed on the appointment of a Director, the Director
shall serve indefinitely until his earlier death, resignation or removal.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.5.</TD><TD STYLE="text-align: justify">A director may be removed from office with or without cause by:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">a Resolution of Members called for the purposes of removing the director or for purposes including the
removal of the director or by a written resolution passed by a least seventy five per cent of the Members of the Company entitled to vote,
provided that no director appointed from the closing of the IPO until consummation of the initial Business Combination may be removed
by a Resolution of Members; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">a Resolution of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.6.</TD><TD STYLE="text-align: justify">A Director may resign his office by giving written notice of his resignation to the Company and the resignation
has effect from the date the notice is received by the Company at the office of its registered agent or from such later date as may be
specified in the notice. A director shall resign forthwith as a Director if he is, or becomes, disqualified from acting as a director
under the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.7.</TD><TD STYLE="text-align: justify">The Directors may at any time appoint any person to be a Director either to fill a vacancy or as an addition
to the existing Directors. Where the Directors appoint a person as Director to fill a vacancy, the term shall not exceed the term that
remained when the Director being replaced ceased to hold office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.8.</TD><TD STYLE="text-align: justify">A vacancy in relation to Directors occurs if a Director dies or otherwise ceases to hold office prior
to the expiration of his term of office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.9.</TD><TD STYLE="text-align: justify">The Company shall keep a register of directors complying with the Act containing:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">the names and addresses of the persons who are Directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">the date on which each person whose name is entered in the register of Directors was appointed as a Director
of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">the date on which each person named as a Director ceased to be a Director of the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">such other information as may be prescribed by the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.10.</TD><TD STYLE="text-align: justify">The register of Directors may be kept in any such form as the Directors may approve, but if it is in magnetic,
electronic or other data storage form, the Company must be able to produce legible evidence of its contents. Until a Resolution of Directors
determining otherwise is passed, the magnetic, electronic or other data storage shall be the original register of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.11.</TD><TD STYLE="text-align: justify">A Director is not required to hold a Share as a qualification to office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify">REMUNERATION OF DIRECTORS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">10.1.</TD><TD STYLE="text-align: justify">The remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall
determine, provided that no remuneration shall be paid to any Director prior to the consummation of a Business Combination. The Directors
shall also, whether prior to or after the consummation of a Business Combination, be entitled to be paid all travelling, hotel and other
expenses properly incurred by them in connection with their attendance at meetings of Directors or committees of Directors, or general
meetings of the Company, or separate meetings of the holders of any class of Shares or debentures of the Company, or otherwise in connection
with the business of the Company or the discharge of their duties as a Director, or to receive a fixed allowance in respect thereof as
may be determined by the Directors, or a combination partly of one such method and partly the other.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">10.2.</TD><TD STYLE="text-align: justify">The Directors may by resolution approve additional remuneration to any Director for any services which
in the opinion of the Directors go beyond his ordinary routine work as a Director. Any fees paid to a Director who is also counsel, attorney
or solicitor to the Company (collectively an &ldquo;<B>Advisor</B>&rdquo;), or otherwise serves in his capacity as an Advisor shall be
separately remunerated for services provided as an Advisor in addition to his remuneration as a Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify">POWERS OF DIRECTORS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">11.1.</TD><TD STYLE="text-align: justify">The business and affairs of the Company shall be managed by, or under the direction or supervision of,
the Directors. The Directors have all the powers necessary for managing, and for directing and supervising, the business and affairs of
the Company. The Directors may pay all expenses incurred preliminary to and in connection with the incorporation of the Company and may
exercise all such powers of the Company as are not by the Act or by the Memorandum or the Articles required to be exercised by the Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">11.2.</TD><TD STYLE="text-align: justify">If the Company is the wholly owned subsidiary of a holding company, a director of the Company may, when
exercising powers or performing duties as a director, act in a manner which he believes is in the best interests of the holding company
even though it may not be in the best interests of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">11.3.</TD><TD STYLE="text-align: justify">If the Company is a subsidiary, but not a wholly owned subsidiary, of a holding company, and the Members
other than the holding company agree in advance, a director of the Company may, when exercising powers or performing duties as a director
in connection with the carrying out of the joint venture, act in a manner which he believes is in the best interests of a Member or some
Members even though it may not be in the best interests of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">11.4.</TD><TD STYLE="text-align: justify">If the Company is carrying out a joint venture between Members, a director of the Company may, when exercising
powers or performing duties as a director, act in a manner which he believes is in the best interests of the holding company even though
it may not be in the best interests of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">11.5.</TD><TD STYLE="text-align: justify">Each Director shall exercise his powers for a proper purpose and shall not act or agree to the Company
acting in a manner that contravenes the Memorandum, the Articles or the Act. Each Director, in exercising his powers or performing his
duties, shall act honestly and in good faith in what the Director believes to be the best interests of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">11.6.</TD><TD STYLE="text-align: justify">The Directors may by Resolution of Directors exercise all the powers of the Company to incur indebtedness,
liabilities or obligations and to secure indebtedness, liabilities or obligations whether of the Company or of any third party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">11.7.</TD><TD STYLE="text-align: justify">All cheques, promissory notes, drafts, bills of exchange and other negotiable instruments and all receipts
for moneys paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed, as the case may be, in such manner as
shall from time to time be determined by Resolution of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">11.8.</TD><TD STYLE="text-align: justify">Section 175 of the Act shall not apply to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify">PROCEEDINGS OF DIRECTORS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">12.1.</TD><TD STYLE="text-align: justify">Any one director of the Company may call a meeting of the Directors by sending a written notice to all
other Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">12.2.</TD><TD STYLE="text-align: justify">The Directors or any committee thereof may meet at such times
and in such manner and places within or outside the British Virgin Islands as the notice calling the meeting provides.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">12.3.</TD><TD STYLE="text-align: justify">A Director is deemed to be present at a meeting of Directors if he participates by telephone or other
electronic means and all Directors participating in the meeting are able to hear each other.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">12.4.</TD><TD STYLE="text-align: justify">A Director shall be given not less than three days&rsquo; notice of meetings of Directors, but a meeting
of Directors held without three days&rsquo; notice having been given to all Directors shall be valid if all the Directors entitled to
vote at the meeting waive notice of the meeting, and for this purpose the presence of a Director at a meeting shall constitute waiver
by that director. The inadvertent failure to give notice of a meeting to a Director, or the fact that a Director has not received the
notice, does not invalidate the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">12.5.</TD><TD STYLE="text-align: justify">A meeting of Directors is duly constituted for all purposes if at the commencement of the meeting there
are present in person not less than one-half of the total number of Directors, unless there are only two Directors in which case the quorum
is two.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">12.6.</TD><TD STYLE="text-align: justify">If the Company has only one Director the provisions herein contained for meetings of Directors do not
apply and such sole Director has full power to represent and act for the Company in all matters as are not by the Act, the Memorandum
or the Articles required to be exercised by the Members. In lieu of minutes of a meeting the sole Director shall record in writing and
sign a note or memorandum of all matters requiring a Resolution of Directors. Such a note or memorandum constitutes sufficient evidence
of such resolution for all purposes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">12.7.</TD><TD STYLE="text-align: justify">At meetings of Directors at which the chairman of the Board is present, he shall preside as chairman of
the meeting. If there is no chairman of the Board or if the chairman of the Board is not present, the Directors present shall choose one
of their number to be chairman of the meeting. If the Directors are unable to choose a chairman for any reason, then the longest standing
Director present shall take the chair.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">12.8.</TD><TD STYLE="text-align: justify">An action that may be taken by the Directors or a committee of directors at a meeting may also be taken
by a Resolution of Directors or a resolution of a committee of Directors consented to in writing by all Directors or by all members of
the committee, as the case may be, without the need for any notice. The consent may be in the form of counterparts each counterpart being
signed by one or more Directors. If the consent is in one or more counterparts, and the counterparts bear different dates, then the resolution
shall take effect on the date upon which the last director has consented to the resolution by signed counterparts.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify">COMMITTEES</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">13.1.</TD><TD STYLE="text-align: justify">The Directors may, by Resolution of Directors, designate one or more committees, each consisting of one
or more Directors, and delegate one or more of their powers, including the power to affix the Seal, to the committee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">13.2.</TD><TD STYLE="text-align: justify">The Directors have no power to delegate to a committee of directors any of the following powers:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">to amend the Memorandum or the Articles:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">to designate committees of directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">to delegate powers to a committee of Directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">to appoint Directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify">to appoint an agent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify">to approve a plan of merger, consolidation or arrangement; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify">to make a declaration of solvency or to approve a liquidation plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">13.3.</TD><TD STYLE="text-align: justify">Regulations 13.2(b) and 13.2(c) do not prevent a committee of Directors, where authorized by the Resolution
of Directors appointing such committee or by a subsequent Resolution of Directors, from appointing a sub-committee and delegating powers
exercisable by the committee to the sub-committee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">13.4.</TD><TD STYLE="text-align: justify">The meetings and proceedings of each committee of Directors consisting of 2 or more Directors shall be
governed <I>mutatis mutandis</I> by the provisions of the Articles regulating the proceedings of Directors so far as the same are not
superseded by any provisions in the Resolution of Directors establishing the committee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify">OFFICERS AND AGENTS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.1.</TD><TD STYLE="text-align: justify">The Company may by Resolution of Directors appoint officers of the Company at such times as may be considered
necessary or expedient. Such officers may consist of a chairman of the Board of Directors, a Chief Executive Officer, one or more vice-
presidents, secretaries and treasurers and such other officers as may from time to time be considered necessary or expedient. Any number
of offices may be held by the same person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.2.</TD><TD STYLE="text-align: justify">The officers shall perform such duties as are prescribed at the time of their appointment subject to any
modification in such duties as may be prescribed thereafter by Resolution of Directors. In the absence of any specific prescription of
duties it shall be the responsibility of the chairman of the Board to preside at meetings of Directors and Members, the Chief Executive
Officer to manage the day to day affairs of the Company, the vice-presidents to act in order of seniority in the absence of the Chief
Executive Officer but otherwise to perform such duties as may be delegated to them by the Chief Executive Officer, the secretaries to
maintain the share register, minute books and records (other than financial records) of the Company and to ensure compliance with all
procedural requirements imposed on the Company by applicable law, and the treasurer to be responsible for the financial affairs of the
Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.3.</TD><TD STYLE="text-align: justify">The emoluments of all officers shall be fixed by Resolution of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.4.</TD><TD STYLE="text-align: justify">The officers of the Company shall hold office until their death, resignation or removal. Any officer elected
or appointed by the Directors may be removed at any time, with or without cause, by Resolution of Directors. Any vacancy occurring in
any office of the Company may be filled by Resolution of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.5.</TD><TD STYLE="text-align: justify">The Resolution of Directors appointing an agent may authorize the agent to appoint one or more substitutes
or delegates to exercise some or all of the powers conferred on the agent by the Company. The Directors may remove an agent appointed
by the Company and may revoke or vary a power conferred on him.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify">FINANCIAL YEAR</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">15.1.</TD><TD STYLE="text-align: justify">Unless the Directors otherwise prescribe, the financial year of the Company shall end on 31st December
in each year and, following the year of incorporation, shall begin on 1st January in each year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify">TRANSFER BY WAY OF CONTINUATION</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">16.1.</TD><TD STYLE="text-align: justify">The Company may by Resolution of the Directors have the power to register by way of continuation as a
body corporate under the laws of any jurisdiction outside the British Virgin Islands and to be deregistered in the British Virgin Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify">MERGERS AND CONSOLIDATIONS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">17.1.</TD><TD STYLE="text-align: justify">The Company shall have the power to merge or consolidate with one or more other constituent companies
upon such terms as the Directors may determine by a Resolution of the Directors subject as may be permitted by the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify">BUSINESS COMBINATION</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.1.</TD><TD STYLE="text-align: justify">Notwithstanding any other Regulations of the Articles, this Regulation 18 shall apply during the period
commencing upon the adoption of the Articles and terminating upon the first to occur of the consummation of any Business Combination and
the distribution of the Trust Fund pursuant to Regulation 18.6. In the event of a conflict between this Regulation 18 and any other Regulation,
the provisions of this Regulation 18 shall prevail, and this Regulation may not be amended prior to the consummation of a Business Combination
without the approval of a Resolution of Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.2.</TD><TD STYLE="text-align: justify">Prior to the consummation of any Business Combination, the Company shall either:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">submit such Business Combination to its Members for approval; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">provide Members with the opportunity to have their Shares repurchased by means of a tender offer for an
amount equal to their pro rata share of the Trust Fund, provided that the Company shall not repurchase Shares in an amount that would
cause the Company&rsquo;s net tangible assets to be less than US$5,000,001.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.3.</TD><TD STYLE="text-align: justify">The Company shall initiate any tender offer in accordance with Rule 13e-4 and Regulation 14E of the Exchange
Act, and shall file tender offer documents with the SEC prior to completing a Business Combination which contain substantially the same
financial and other information about such Business Combination and the redemption rights as is required under Regulation 14A of the Exchange
Act, to repurchase Public Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.4.</TD><TD STYLE="text-align: justify">At a general meeting called for the purposes of approving a Business Combination pursuant to this Regulation,
in the event that a majority of the Shares voted are voted for the approval of the Business Combination, the Company shall be authorised
to consummate the Business Combination, provided that the Company shall not consummate any Business Combination unless the Company has
net tangible assets of at least US$5,000,001 upon such consummation or any greater net tangible asset or cash requirement that may be
contained in the agreement relating to the Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.5.</TD><TD STYLE="text-align: justify">Any Member holding Shares issued to persons who are not a Founder, officer of the Company or Director
may, contemporaneously with any vote on a Business Combination, elect to have their Public Shares redeemed for cash (the &ldquo;<B>IPO
Redemption</B>&rdquo;), provided that the Member follows the applicable procedures for redemption specified in the applicable disclosure
documents. If so demanded, the Company shall pay any such redeeming Member, regardless of whether he is voting for or against such proposed
Business Combination, a per Share redemption price equal to their pro rata share of the Trust Fund (such redemption price being referred
to herein as the &ldquo;<B>Redemption Price</B>&rdquo;). The Redemption Price shall be paid promptly following the consummation of the relevant
Business Combination. If the proposed Business Combination is not approved or completed for any reason then such redemptions shall be
cancelled and share certificates (if any) returned to the relevant Members as appropriate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.6.</TD><TD STYLE="text-align: justify">(A) The Company shall consummate an initial Business Combination on or before January 23, 2023 (the
                                                              &ldquo;<B>Deadline</B>&rdquo;), which Deadline may be extended by the Company by Resolution of Directors in up to three (3) separate
                                                              instances (each, an &ldquo;<B>Extension</B>&rdquo;) by an additional one (1) month each, for a total of up to three (3) months (each
                                                              period as extended an &ldquo;<B>Extension Period&rdquo;) </B>without another shareholder vote, provided that if the Company
                                                              exercises the Extension, then the Founders, or their affiliates or designees, shall, upon five (5) days advance notice prior to the
                                                              Deadline, deposit into the Trust Fund, US$0.04 per Public Share outstanding (the &ldquo;<B>Top-up Amount</B>&rdquo;) on or prior to
                                                              the Deadline or the Deadline as extended by any Extension Period validly exercised under this Article 18.6(A).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="text-align: justify">(B) If the Company does not complete its initial Business Combination on or before the earlier of
                                                                           (i) the Deadline, where no Extension is validly exercised under Article 18.6(A), or (ii) the Deadline, as extended by any Extension
                                                                           Period validly exercised under Article 18.6(A), or (iii) April&nbsp;23, 2023 (the &ldquo;<B>Extended <U>Deadline</U></B>&rdquo;), or
                                                                           if any Top-Up Amount is not paid in full by the Founders as required under Article 18.6(A), the Company shall, as promptly as
                                                                           reasonably possible but not more than five&nbsp;business days thereafter, redeem 100% of the outstanding Public Shares for a pro
                                                                           rata portion of the funds held in the Trust Fund, including a pro rata portion of any interest earned, but excluding all expenses
                                                                           paid and reserves for expenses and taxes payable.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.7.</TD><TD STYLE="text-align: justify">A holder of Public Shares shall be entitled to receive distributions from the Trust Fund only in the event
of an IPO Redemption, a repurchase of Shares by means of a tender offer pursuant to Regulation 18.2(b), or a distribution of the Trust
Fund pursuant to Regulation 18.6. In no other circumstance shall a holder of Public Shares have any right or interest of any kind in the
Trust Fund.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.8.</TD><TD STYLE="text-align: justify">After the issue of Public Shares, and prior to the consummation of a Business Combination, the Directors
shall not issue additional Shares or any other Securities that participate in any manner in the Trust Fund or that vote as a class with
Public Shares on any Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.9.</TD><TD STYLE="text-align: justify">The uninterested independent Directors shall approve any transaction or transactions between the Company
and any of the following parties:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">any Member owning an interest in the voting power of the Company that gives such Member a significant
influence over the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">any Director or executive officer of the Company and any affiliate or relative of such Director or executive
officer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.10.</TD><TD STYLE="text-align: justify">A Director may vote in respect of any Business Combination in which such Director has a conflict of interest
with respect to the evaluation of such Business Combination. Such Director must disclose such interest or conflict to the other Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.11.</TD><TD STYLE="text-align: justify">The Audit Committee shall monitor compliance with the terms of the IPO and, if any non-compliance is identified,
the Audit Committee shall be charged with the responsibility to take all action necessary to rectify such non-compliance or otherwise
cause compliance with the terms of the IPO.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.12.</TD><TD STYLE="text-align: justify">The Company may enter into a Business Combination with a target business that is affiliated with the Sponsor,
the Directors or executive officers of the Company and in such event the Company will obtain an opinion from an independent investment
banking or accounting firm that the Business Combination is fair to the Shareholders from a financial point of view.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.13.</TD><TD STYLE="text-align: justify">The Company will not enter into a Business Combination with a target business that is a blank check company
or a similar company with nominal operations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">19.</TD><TD STYLE="text-align: justify">CONFLICT OF INTERESTS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">19.1.</TD><TD STYLE="text-align: justify">A director of the Company shall, forthwith after becoming aware of the fact that he is interested in a
transaction entered into or to be entered into by the Company, disclose the interest to all other Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">19.2.</TD><TD STYLE="text-align: justify">For the purposes of Regulation 19.1, a disclosure to all other Directors to the effect that a Director
is a member, director or officer of another named entity or has a fiduciary relationship with respect to the entity or a named individual
and is to be regarded as interested in any transaction which may, after the date of the entry or disclosure, be entered into with that
entity or individual, is a sufficient disclosure of interest in relation to that transaction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">19.3.</TD><TD STYLE="text-align: justify">Subject to any rules or regulations of the Designated Exchange or any laws or regulations governing companies
listed on the Designated Exchange, a Director who is interested in a transaction entered into or to be entered into by the Company may:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">vote on a matter relating to the transaction;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">attend a meeting of Directors at which a matter relating to the transaction arises and be included among
the Directors present at the meeting for the purposes of a quorum; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">sign a document on behalf of the Company, or do any other thing in his capacity as a Director, that relates
to the transaction, and, subject to compliance with the Act shall not, by reason of his office be accountable to the Company for any benefit
which he derives from such transaction and no such transaction shall be liable to be avoided on the grounds of any such interest or benefit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">20.</TD><TD STYLE="text-align: justify">INDEMNIFICATION</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">20.1.</TD><TD STYLE="text-align: justify">Subject to the limitations hereinafter provided the Company shall indemnify against all expenses, including
legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative
or investigative proceedings any person who:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">is or was a party or is threatened to be made a party to any threatened, pending or completed proceedings,
whether civil, criminal, administrative or investigative, by reason of the fact that the person is or was a director of the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">is or was, at the request of the Company, serving as a director of, or in any other capacity is or was
acting for, another company or a partnership, joint venture, trust or other enterprise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">20.2.</TD><TD STYLE="text-align: justify">The indemnity in Regulation 20.1 only applies if the person acted honestly and in good faith with a view
to what that person believed were the best interests of the Company and, in the case of criminal proceedings, the person had no reasonable
cause to believe that their conduct was unlawful.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">20.3.</TD><TD STYLE="text-align: justify">The decision of the Directors as to whether the person acted honestly and in good faith and with a view
to the best interests of the Company and as to whether the person had no reasonable cause to believe that his conduct was unlawful is,
in the absence of fraud, sufficient for the purposes of the Articles, unless a question of law is involved.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">20.4.</TD><TD STYLE="text-align: justify">The termination of any proceedings by any judgment, order, settlement, conviction or the entering of a
<I>nolle prosequi</I> does not, by itself, create a presumption that the person did not act honestly and in good faith and with a view
to the best interests of the Company or that the person had reasonable cause to believe that his conduct was unlawful.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">20.5.</TD><TD STYLE="text-align: justify">The Company may purchase and maintain insurance in relation to any person who is or was a director, officer
or liquidator of the Company, or who at the request of the Company is or was serving as a director, officer or liquidator of, or in any
other capacity is or was acting for, another company or a partnership, joint venture, trust or other enterprise, against any liability
asserted against the person and incurred by the person in that capacity, whether or not the Company has or would have had the power to
indemnify the person against the liability as provided in the Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">21.</TD><TD STYLE="text-align: justify">RECORDS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">21.1.</TD><TD STYLE="text-align: justify">The Company shall keep the following documents at the office of its registered agent:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">the Memorandum and the Articles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">the Register of Members, or a copy of the Register of Members;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">the register of Directors, or a copy of the register of Directors; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">copies of all notices and other documents filed by the Company with the Registrar of Corporate Affairs
in the previous 10 years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">21.2.</TD><TD STYLE="text-align: justify">If the Company maintains only a single copy of the Register of Members or a copy of the register of Directors
at the office of its registered agent, it shall:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">within 15 days of any change in either register, notify the registered agent in writing of the change;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">provide the registered agent with a written record of the physical address of the place or places at which
the original Register of Members or the original register of Directors is kept.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">21.3.</TD><TD STYLE="text-align: justify">The Company shall keep the following records at the office of its registered agent or at such other place
or places, within or outside the British Virgin Islands, as the Directors may determine:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">minutes of meetings and Resolutions of Members and classes of Members;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">minutes of meetings and Resolutions of Directors and committees of Directors; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">an impression of the Seal, if any.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">21.4.</TD><TD STYLE="text-align: justify">Where any original records referred to in this Regulation are maintained other than at the office of the
registered agent of the Company, and the place at which the original records is changed, the Company shall provide the registered agent
with the physical address of the new location of the records of the Company within 14 days of the change of location.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">21.5.</TD><TD STYLE="text-align: justify">The records kept by the Company under this Regulation shall be in written form or either wholly or partly
as electronic records.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">22.</TD><TD STYLE="text-align: justify">REGISTERS OF CHARGES</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">22.1.</TD><TD STYLE="text-align: justify">The Company shall maintain at the office of its registered agent a register of charges in which there
shall be entered the following particulars regarding each mortgage, charge and other encumbrance created by the Company:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">the date of creation of the charge;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">a short description of the liability secured by the charge;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">a short description of the property charged;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">the name and address of the trustee for the security or, if there is no such trustee, the name and address
of the chargee;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify">unless the charge is a security to bearer, the name and address of the holder of the charge; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify">details of any prohibition or restriction contained in the instrument creating the charge on the power
of the Company to create any future charge ranking in priority to or equally with the charge.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 61.5pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">23.</TD><TD STYLE="text-align: justify">SEAL</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">23.1.</TD><TD STYLE="text-align: justify">The Company may have more than one Seal and references herein to the Seal shall be references to every
Seal which shall have been duly adopted by Resolution of Directors. The Directors shall provide for the safe custody of the Seal and for
an imprint thereof to be kept at the registered office. Except as otherwise expressly provided herein the Seal when affixed to any written
instrument shall be witnessed and attested to by the signature of any one director or other person so authorized from time to time by
Resolution of Directors. Such authorization may be before or after the Seal is affixed, may be general or specific and may refer to any
number of sealings. The Directors may provide for a facsimile of the Seal and of the signature of any director or authorized person which
may be reproduced by printing or other means on any instrument and it shall have the same force and validity as if the Seal had been affixed
to such instrument and the same had been attested to as hereinbefore described.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.</TD><TD STYLE="text-align: justify">ACCOUNTS AND AUDIT</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.1.</TD><TD STYLE="text-align: justify">The Company shall keep records that are sufficient to show and explain the Company&rsquo;s transactions
and that will, at any time, enable the financial position of the Company to be determined with reasonable accuracy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.2.</TD><TD STYLE="text-align: justify">The Company may by Resolution of Members call for the Directors to prepare periodically and make available
a profit and loss account and a balance sheet. The profit and loss account and balance sheet shall be drawn up so as to give respectively
a true and fair view of the profit and loss of the Company for a financial period and a true and fair view of the assets and liabilities
of the Company as at the end of a financial period.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.3.</TD><TD STYLE="text-align: justify">The Company may by Resolution of Members call for the accounts to be examined by auditors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.4.</TD><TD STYLE="text-align: justify">The first auditors shall be appointed by Resolution of Directors; subsequent auditors shall be appointed
by a Resolution of Members or a Resolution of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.5.</TD><TD STYLE="text-align: justify">The Directors may establish and maintain an audit committee (the &ldquo;<B>Audit Committee</B>&rdquo;)
as a committee of the Directors and shall adopt a formal written Audit Committee charter and review and assess the adequacy of the formal
written charter on an annual basis. The composition and responsibilities of the Audit Committee shall comply with the rules and regulations
of the SEC and the Designated Stock Exchange. Once formed, the Audit Committee shall meet at least once every financial quarter, or more
frequently as the circumstances dictate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.6.</TD><TD STYLE="text-align: justify">The auditors may be Members, but no director or other officer shall be eligible to be an auditor of the
Company during their continuance in office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.7.</TD><TD STYLE="text-align: justify">The remuneration of the auditors of the Company:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">in the case of auditors appointed by the Directors, may be fixed by Resolution of Directors; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">subject to the foregoing, shall be fixed by Resolution of Members or in such manner as the Company may
by Resolution of Members determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.8.</TD><TD STYLE="text-align: justify">The auditors shall examine each profit and loss account and balance sheet required to be laid before a
meeting of the Members or otherwise given to Members and shall state in a written report whether or not:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">in their opinion the profit and loss account and balance sheet give a true and fair view respectively
of the profit and loss for the period covered by the accounts, and of the assets and liabilities of the Company at the end of that period;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">all the information and explanations required by the auditors have been obtained.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.9.</TD><TD STYLE="text-align: justify">The report of the auditors shall be annexed to the accounts and shall be read at the meeting of Members
at which the accounts are laid before the Company or shall be otherwise given to the Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.10.</TD><TD STYLE="text-align: justify">Every auditor of the Company shall have a right of access at all times to the books of account and vouchers
of the Company, and shall be entitled to require from the Directors and officers of the Company such information and explanations as he
thinks necessary for the performance of the duties of the auditors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">24.11.</TD><TD STYLE="text-align: justify">The auditors of the Company shall be entitled to receive notice of, and to attend any meetings of Members
at which the Company&rsquo;s profit and loss account and balance sheet are to be presented.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">25.</TD><TD STYLE="text-align: justify">TAX FILINGS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">25.1.</TD><TD STYLE="text-align: justify">Each Tax Filing Authorized Person and any such other person, acting alone, as any Director shall designate
from time to time, are authorized to file tax forms SS-4, W-8 BEN, W-8 IMY, W-9, 8832 and 2553 and such other similar tax forms as are
customary to file with any US state or federal governmental authorities or foreign governmental authorities in connection with the formation,
activities and/or elections of the Company and such other tax forms as may be approved from time to time by any Director or officer of
the Company. The Company further ratifies and approves any such filing made by any Tax Filing Authorized Person or such other person prior
to the date of the Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">26.</TD><TD STYLE="text-align: justify">NOTICES</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">26.1.</TD><TD STYLE="text-align: justify">Any notice, information or written statement to be given by the Company to Members may be given by personal
service by mail, facsimile or other similar means of electronic communication, addressed to each Member at the address shown in the share
register.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">26.2.</TD><TD STYLE="text-align: justify">Any summons, notice, order, document, process, information or written statement to be served on the Company
may be served by leaving it, or by sending it by registered mail addressed to the Company, at its registered office, or by leaving it
with, or by sending it by registered mail to, the registered agent of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">26.3.</TD><TD STYLE="text-align: justify">Service of any summons, notice, order, document, process, information or written statement to be served
on the Company may be proved by showing that the summons, notice, order, document, process, information or written statement was delivered
to the registered office or the registered agent of the Company or that it was mailed in such time as to admit to its being delivered
to the registered office or the registered agent of the Company in the normal course of delivery within the period prescribed for service
and was correctly addressed and the postage was prepaid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.75pt; text-align: justify; text-indent: -27.75pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">27.</TD><TD STYLE="text-align: justify">VOLUNTARY WINDING UP</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">27.1.</TD><TD STYLE="text-align: justify">The Company may by a Resolution of Members or by a Resolution of Directors appoint a voluntary liquidator.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">27.2.</TD><TD STYLE="text-align: justify">If the Company does not commence its Business Combination on or before the earlier of (i) the Deadline,
where no Extension is validly exercised under Article 18.6(A), or (ii) the Deadline, as extended by any Extension Period validly exercised
under Article 18.6(A), or (iii) the Extended <U>Deadline</U>, such event shall terminate the existence of the Company and the Company
shall appoint a voluntary liquidator to commence the liquidation of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We, CONYERS TRUST COMPANY (BVI) LIMITED, registered
agent of the Company, of Commerce House, Wickhams Cay 1, PO Box 3140, Road Town, Tortola, British Virgin Islands VG1110 for the purpose
of incorporating a BVI Business Company under the laws of the British Virgin Islands hereby sign these Articles of Association on the
24 May 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporator</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONYERS TRUST COMPANY (BVI) LIMITED</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per: </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew Swapp</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For and on behalf of</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conyers Trust Company (BVI) Limited</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-weight: normal">19</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ea172192ex10-1_brilliant.htm
<DESCRIPTION>PROMISSORY NOTE, DATED JANUARY 20, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;<B>SECURITIES ACT</B>&rdquo;). THIS NOTE HAS BEEN
ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER
THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION
IS NOT REQUIRED.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>P
R O M I S S O R Y N O T E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Amount: $21,350</FONT></TD>
    <TD STYLE="width: 51%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated
    as of January 20, 2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brilliant
Acquisition Corporation, a British Virgin Islands business company (the &ldquo;<B>Maker</B>&rdquo;), promises to pay to the order of
Nukkleus Inc., a Delaware corporation (the &ldquo;<B>Payee</B>&rdquo;) the principal sum of Twenty-One Thousand Three Hundred Fifty Dollars
($21,350) in lawful money of the United States of America, on the terms and conditions described below. All payments on this Promissory
Note (this &ldquo;<B>Note</B>&rdquo;) shall be made by check or wire transfer of immediately available funds or as otherwise determined
by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this
Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal.
                                            </B>The principal balance of this Note shall be payable promptly after the date on which
                                            the Maker consummates an initial business combination (a &ldquo;<B>Business Combination</B>&rdquo;)
                                            with a target business (as described in the Maker&rsquo;s initial public offering prospectus
                                            dated June 23, 2020 (the &ldquo;<B>Prospectus</B>&rdquo;)). The principal balance may be
                                            prepaid at any time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interest.
                                            </B>No interest shall accrue on the unpaid principal balance of this Note.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Convertible;
                                            Non-Recourse</B>. This Note shall not be convertible into any securities of Maker, and Payee
                                            shall have no recourse with respect to the Payee&rsquo;s ability to convert this Note into
                                            any securities of Maker.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application
                                            of Payments. </B>All payments shall be applied first to payment in full of any costs incurred
                                            in the collection of any sum due under this Note, including (without limitation) reasonable
                                            attorney&rsquo;s fees, then to the payment in full of any late charges and finally to the
                                            reduction of the unpaid principal balance of this Note.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Events
                                            of Default.</B> The following shall constitute an event of default (&ldquo;<B>Event of Default</B>&rdquo;):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Failure
                                            to Make Required Payments.</B> Failure by Maker to pay the principal of this Note within
                                            five (5) business days following the date when due.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voluntary
                                            Liquidation, Etc.</B> The commencement by Maker of a proceeding relating to its bankruptcy,
                                            insolvency, reorganization, rehabilitation or other similar action, or the consent by it
                                            to the appointment of, or taking possession by, a receiver, liquidator, assignee, trustee,
                                            custodian, sequestrator (or other similar official) for Maker or for any substantial part
                                            of its property, or the making by it of any assignment for the benefit of creditors, or the
                                            failure of Maker generally to pay its debts as such debts become due, or the taking of corporate
                                            action by Maker in furtherance of any of the foregoing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Involuntary
                                            Bankruptcy, Etc.</B> The entry of a decree or order for relief by a court having jurisdiction
                                            in the premises in respect of Maker in an involuntary case under any applicable bankruptcy,
                                            insolvency or similar law, for the appointing of a receiver, liquidator, assignee, custodian,
                                            trustee, sequestrator (or similar official) for Maker or for any substantial part of its
                                            property, or ordering the winding-up or liquidation of the affairs of Maker, and the continuance
                                            of any such decree or order unstayed and in effect for a period of 60 consecutive days.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Remedies.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            the occurrence of an Event of Default specified in Section 5(a) hereof, the Payee may, by
                                            written notice to Maker, declare this Note to be due immediately and payable, whereupon the
                                            unpaid principal amount of this Note, and all other amounts payable hereunder, shall become
                                            immediately due and payable without presentment, demand, protest or other notice of any kind,
                                            all of which are hereby expressly waived, anything contained herein or in the documents evidencing
                                            the same to the contrary notwithstanding.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            the occurrence of an Event of Default specified in Sections 5(b) and 5(c), the unpaid principal
                                            balance of this Note, and all other sums payable with regard to this Note, shall automatically
                                            and immediately become due and payable, in all cases without any action on the part of the
                                            Payee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Waivers.
                                            </B>Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment
                                            for payment, demand, notice of dishonor, protest, and notice of protest with regard to the
                                            Note, all errors, defects and imperfections in any proceedings instituted by the Payee under
                                            the terms of this Note, and all benefits that might accrue to Maker by virtue of any present
                                            or future laws exempting any property, real or personal, or any part of the proceeds arising
                                            from any sale of any such property, from attachment, levy or sale under execution, or providing
                                            for any stay of execution, exemption from civil process, or extension of time for payment;
                                            and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained
                                            by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ
                                            in whole or in part in any order desired by the Payee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unconditional
                                            Liability. </B>Maker hereby waives all notices in connection with the delivery, acceptance,
                                            performance, default, or enforcement of the payment of this Note, and agrees that its liability
                                            shall be unconditional, without regard to the liability of any other party, and shall not
                                            be affected in any manner by any indulgence, extension of time, renewal, waiver or modification
                                            granted or consented to by the Payee, and consents to any and all extensions of time, renewals,
                                            waivers, or modifications that may be granted by the Payee with respect to the payment or
                                            other provisions of this Note, and agrees that additional makers, endorsers, guarantors,
                                            or sureties may become parties hereto without notice to Maker or affecting Maker&rsquo;s
                                            liability hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices.
                                            </B>Any notice called for hereunder shall be deemed properly given if (i) sent by certified
                                            mail, return receipt requested, (ii) personally delivered, (iii) dispatched by any form of
                                            private or governmental express mail or delivery service providing receipted delivery or
                                            (iv) sent by facsimile or (v) to the following addresses or to such other address as either
                                            party may designate by notice in accordance with this Section:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Maker:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Brilliant Acquisition Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99
Dan Ba Road, C-9, Putuo District,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shanghai,
Peoples Republic of China 200062</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to Payee:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nukkleus
Inc.<BR>
525 Washington Blvd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jersey
City, New Jersey 07310</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
shall be deemed given on the earlier of (i) actual receipt by the receiving party, (ii) the date shown on a facsimile transmission confirmation,
(iii) the date reflected on a signed delivery receipt, or (iv) two (2) Business Days following tender of delivery or dispatch by express
mail or delivery service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Construction.
                                            </B>THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
                                            NEW YORK, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction.
                                            </B>The courts of the State of New York have exclusive jurisdiction to settle any dispute
                                            arising out of or in connection with this agreement (including a dispute relating to any
                                            non-contractual obligations arising out of or in connection with this agreement) and the
                                            parties submit to the exclusive jurisdiction of the courts of New York.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Severability.
                                            </B>Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction
                                            shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability
                                            without invalidating the remaining provisions hereof, and any such prohibition or unenforceability
                                            in any jurisdiction shall not invalidate or render unenforceable such provision in any other
                                            jurisdiction.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trust
                                            Waiver. </B>The Payee has been provided a copy of the Prospectus. Notwithstanding anything
                                            herein to the contrary, the Payee hereby waives any and all right, title, interest or claim
                                            of any kind (&ldquo;<B>Claim</B>&rdquo;) in or to any amounts contained in the trust account
                                            in which the proceeds of the initial public offering (the &ldquo;<B>IPO</B>&rdquo;) conducted
                                            by the Maker and the proceeds of the sale of securities in a private placement that occurred
                                            prior to the effectiveness of the IPO, as described in greater detail in the Prospectus,
                                            were placed, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction
                                            for any Claim from the trust account or any distribution therefrom for any reason whatsoever.
                                            If Maker does not consummate a Business Combination, this Note shall be repaid only from
                                            amounts remaining outside of the trust account, if any.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment;
                                            Waiver. </B>Any amendment hereto or waiver of any provision hereof may be made with, and
                                            only with, the written consent of the Maker and the Payee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assignment.
                                            </B>No assignment or transfer of this Note or any rights or obligations hereunder may be
                                            made by any party hereto (by operation of law or otherwise) without the prior written consent
                                            of the other party hereto and any attempted assignment without the required consent shall
                                            be void.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Further
                                            Assurance. </B>The Maker shall, at its own cost and expense, execute and do (or procure to
                                            be executed and done by any other necessary party) all such deeds, documents, acts and things
                                            as the Payee may from time to time require as may be necessary to give full effect to this
                                            Note.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
rest of this page is intentionally left blank]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed on the day and year first above
written.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">BRILLIANT ACQUISITION CORPORATION</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ Peng Jiang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>Peng Jiang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chairman and CEO</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and Agreed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">NUKKLEUS INC.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">/s/ Emil Assentato</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>Emil Assentato</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Promissory Note]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ea172192ex99-1_brilliant.htm
<DESCRIPTION>PRESS RELEASE, DATED JANUARY 24, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Brilliant
Acquisition Corporation Announces Extension of Completion Window to February 23, 2023</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>January
24, 2023 | Source: Brilliant Acquisition Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (&#8220;Brilliant&#8221;) announced today that it has extended
the period of time it will have to consummate its initial business combination by a further one month, or until February 23, 2023. In
connection with the extension, Nukkleus, Inc. (&#8220;Nukkleus&#8221;) has deposited $21,350 in Brilliant&#8217;s trust account, representing
$0.0525 per public ordinary share of Brilliant currently outstanding, as additional interest on the proceeds in the trust account. The
extension was approved by Brilliant&#8217;s shareholders on January 19, 2023. The shareholder approval also permits Brilliant to further
extend Brilliant&#8217;s initial business combination deadline on a monthly basis up to a further two months, or until April 23, 2023.&nbsp;
Nukkleus will deposit an additional $32,500 in the trust account for any such additional monthly extension, representing $0.08 per public
ordinary share of Brilliant outstanding.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the extension is to permit sufficient time for Brilliant to consummate its previously announced proposed business combination
with Nukkleus. For a summary of the material terms of the proposed business combination, please see Brilliant&#8217;s Current Report
on Form 8-K filed on February 23, 2022 and Nukkleus&#8217;s Registration Statement on Form S-4 initially filed on April 15, 2022 (as
amended to date), with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) in connection with the announcement of the
proposed business combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Brilliant Acquisition Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brilliant
(Nasdaq: BRLI) is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, or other
similar business combination with one or more businesses or entities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
Information and Where to Find It</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release relates to a proposed business combination transaction between Nukkleus and Brilliant pursuant to which Nukkleus will become
the parent company of Brilliant upon the closing of the transactions. In connection with the proposed transaction, Nukkleus has filed
with the SEC a Registration Statement on Form S-4, including a proxy statement (the &#8220;proxy statement&#8221;). The definitive proxy
statement (if and when available) will be delivered to Nukkleus&#8217;s and Brilliant&#8217;s shareholders. Each of Nukkleus and Brilliant
may also file other relevant documents regarding the proposed transaction with the SEC. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION,
INVESTORS AND SECURITY HOLDERS OF NUKKLEUS AND BRILLIANT ARE URGED TO READ THE REGISTRATION STATEMENT, PROXY STATEMENT AND ALL OTHER
RELEVANT DOCUMENTS THAT ARE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION, INCLUDING ANY AMENDMENTS OR SUPPLEMENTS TO
THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
and security holders may obtain free copies of the proxy statement (if and when available) and other documents that are filed or will
be filed with the SEC by Nukkleus or Brilliant through the website maintained by the SEC at www.sec.gov. Stockholders of Nukkleus will
also be able to obtain a copy of the definitive proxy statement, without charge by directing a request to: Nukkleus, Inc., 525 Washington
Boulevard, Jersey City, New Jersey 07310. Shareholders of Brilliant will also be able to obtain a copy of the definitive proxy statement,
without charge by directing a request to: Brilliant Acquisition Corporation, 99 Dan Ba Road, C-9, Putuo District, Shanghai, Peoples Republic
of China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Participants
in the Solicitation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nukkleus
and its directors and executive officers are participants in the solicitation of proxies from the stockholders of Nukkleus in respect
of the proposed transaction. Information about Nukkleus&#8217;s directors and executive officers and their ownership of Nukkleus common
stock is set forth in Nukkleus&#8217;s Annual Report on Form 10-K for the year ended September 30, 2021, filed with the SEC on December
29, 2021. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests,
by security holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with
the SEC in respect of the proposed transaction when they become available. You may obtain free copies of these documents as described
in the preceding paragraph.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brilliant
and its directors and executive officers are participants in the solicitation of proxies from the shareholders of Brilliant in respect
of the proposed transaction. Information about Brilliant&#8217;s directors and executive officers and their ownership of Brilliant&#8217;s
ordinary shares is set forth in Brilliant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC
on March 31, 2022. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect
interests, by security holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be
filed with the SEC in respect of the proposed transaction when they become available. You may obtain free copies of these documents as
described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward
Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that
are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to
differ from the forward-looking statements. Brilliant expressly disclaims any obligations or undertaking to release publicly any updates
or revisions to any forward-looking statements contained herein to reflect any change in Brilliant&#8217;s expectations with respect
thereto or any change in events, conditions or circumstances on which any statement is based.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Peng Jiang<BR>
Chief Executive Officer<BR>
Brilliant Acquisition Corporation<BR>
+ (86) 021-80125497</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>brli-20230119.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 86o5s7xRiXhun8uDb31cWa6KCaPty5BxCZkxsmxyHZka7y8nusqaxSCbn+3mcRYP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:BRLI="http://brilliant.com/20230119" elementFormDefault="qualified" targetNamespace="http://brilliant.com/20230119">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://brilliant.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="brli-20230119_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="brli-20230119_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="brli-20230119_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" name="UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BRLI_OrdinarySharesNoParValuePerShareMember" name="OrdinarySharesNoParValuePerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" name="RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" name="WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>brli-20230119_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://brilliant.com/role/Cover" xlink:href="brli-20230119.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://brilliant.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" xlink:label="loc_BRLIUnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BRLIUnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_BRLIOrdinarySharesNoParValuePerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BRLIOrdinarySharesNoParValuePerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" xlink:label="loc_BRLIRightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BRLIRightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" xlink:label="loc_BRLIWarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BRLIWarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>brli-20230119_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" xlink:label="BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" xlink:to="BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember_lbl" xml:lang="en-US">Units, each consisting of one Ordinary Share, one Right and one Redeemable Warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_OrdinarySharesNoParValuePerShareMember" xlink:label="BRLI_OrdinarySharesNoParValuePerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BRLI_OrdinarySharesNoParValuePerShareMember" xlink:to="BRLI_OrdinarySharesNoParValuePerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BRLI_OrdinarySharesNoParValuePerShareMember_lbl" xml:lang="en-US">Ordinary Shares, no par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" xlink:label="BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" xlink:to="BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember_lbl" xml:lang="en-US">Rights, each right entitling the holder to 1/10 of one Ordinary Share</link:label>
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" xlink:label="BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" xlink:to="BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember_lbl" xml:lang="en-US">Warrants, each warrant exercisable for one Ordinary Share for $11.50 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>brli-20230119_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://brilliant.com/role/Cover" xlink:href="brli-20230119.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://brilliant.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" xlink:label="loc_BRLIUnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BRLIUnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_BRLIOrdinarySharesNoParValuePerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BRLIOrdinarySharesNoParValuePerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" xlink:label="loc_BRLIRightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BRLIRightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="brli-20230119.xsd#BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" xlink:label="loc_BRLIWarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BRLIWarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140539310290512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 19,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BRILLIANT ACQUISITION CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001787518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">D8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">99
Dan Ba Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">C-9,
Putuo District<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Shanghai<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">00000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">021-80125497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember', window );">Units, each consisting of one Ordinary Share, one Right and one Redeemable Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Units, each consisting of one Ordinary Share, one Right and one Redeemable Warrant<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BRLIU<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BRLI_OrdinarySharesNoParValuePerShareMember', window );">Ordinary Shares, no par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BRLI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember', window );">Rights, each right entitling the holder to 1/10 of one Ordinary Share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Rights, each right entitling the holder to 1/10 of one Ordinary Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BRLIR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember', window );">Warrants, each warrant exercisable for one Ordinary Share for $11.50 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each warrant exercisable for one Ordinary Share for $11.50 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BRLIW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BRLI_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BRLI_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>ea172192-8k425_brilliant_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BRLI="http://brilliant.com/20230119"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="brli-20230119.xsd" xlink:type="simple"/>
    <context id="From2023-01-19to2023-01-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001787518</identifier>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <context id="From2023-01-192023-01-19_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001787518</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRLI:UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <context id="From2023-01-192023-01-19_custom_OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001787518</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRLI:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <context id="From2023-01-192023-01-19_custom_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001787518</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRLI:RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <context id="From2023-01-192023-01-19_custom_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001787518</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BRLI:WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-01-19to2023-01-19">0001787518</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-01-19to2023-01-19">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-01-19to2023-01-19">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityAddressPostalZipCode contextRef="From2023-01-19to2023-01-19">00000</dei:EntityAddressPostalZipCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-01-19to2023-01-19" id="xdx2ixbrl0016">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType contextRef="From2023-01-19to2023-01-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-01-19to2023-01-19">2023-01-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-01-19to2023-01-19">BRILLIANT ACQUISITION CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-19to2023-01-19">D8</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-01-19to2023-01-19">001-39341</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-01-19to2023-01-19">99 Dan Ba Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-01-19to2023-01-19">C-9, Putuo District</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-01-19to2023-01-19">Shanghai</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2023-01-19to2023-01-19">CN</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="From2023-01-19to2023-01-19">86</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-01-19to2023-01-19">021-80125497</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-01-19to2023-01-19">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-01-19to2023-01-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-01-19to2023-01-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-01-19to2023-01-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-01-192023-01-19_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember">Units, each consisting of one Ordinary Share, one Right and one Redeemable Warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-192023-01-19_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember">BRLIU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-192023-01-19_custom_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-01-192023-01-19_custom_OrdinarySharesNoParValuePerShareMember">Ordinary Shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-192023-01-19_custom_OrdinarySharesNoParValuePerShareMember">BRLI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-192023-01-19_custom_OrdinarySharesNoParValuePerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-01-192023-01-19_custom_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember">Rights, each right entitling the holder to 1/10 of one Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-192023-01-19_custom_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember">BRLIR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-192023-01-19_custom_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-01-192023-01-19_custom_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember">Warrants, each warrant exercisable for one Ordinary Share for $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-192023-01-19_custom_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember">BRLIW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-192023-01-19_custom_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-01-19to2023-01-19">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-01-19to2023-01-19">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M4Z:>+G@B5^<MVMI>F(AE;.R%3O\L9TL^Y>8N'RLXZU0JD4AYIH7,B.*+\]:
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MIN5AS!GXCKT!/E](:;8G]CU*]1JL_Q]02P,$%     @ ZX$Y5N#T.HFJ @
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M?P%02P$"% ,4    " #K@3E6!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .N!.5;8KU\J[@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( .N!.5:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ ZX$Y5OXC:U&W!0  $AL  !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( .N!.5;@]#J)J@(  # ,   -              "  ?H-  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ ZX$Y5I>*NQS     $P(   L
M ( !SQ   %]R96QS+RYR96QS4$L! A0#%     @ ZX$Y5JK$(A8S 0  (@(
M  \              ( !N!$  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M .N!.58D'INBK0   /@!   :              "  1@3  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .N!.59ED'F2&0$  ,\#   3
M              "  ?T3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  $<5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>5</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea172192-8k425_brilliant.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brilliant.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressPostalZipCode -  ea172192-8k425_brilliant.htm 24</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="ea172192-8k425_brilliant.htm">ea172192-8k425_brilliant.htm</File>
    <File>brli-20230119.xsd</File>
    <File>brli-20230119_def.xml</File>
    <File>brli-20230119_lab.xml</File>
    <File>brli-20230119_pre.xml</File>
    <File>ea172192ex10-1_brilliant.htm</File>
    <File>ea172192ex2-2_brilliant.htm</File>
    <File>ea172192ex3-1_brilliant.htm</File>
    <File>ea172192ex99-1_brilliant.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="34">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea172192-8k425_brilliant.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 34
   },
   "contextCount": 5,
   "dts": {
    "definitionLink": {
     "local": [
      "brli-20230119_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ea172192-8k425_brilliant.htm"
     ]
    },
    "labelLink": {
     "local": [
      "brli-20230119_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "brli-20230119_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "brli-20230119.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 67,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 0,
   "keyStandard": 25,
   "memberCustom": 4,
   "memberStandard": 0,
   "nsprefix": "BRLI",
   "nsuri": "http://brilliant.com/20230119",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea172192-8k425_brilliant.htm",
      "contextRef": "From2023-01-19to2023-01-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://brilliant.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea172192-8k425_brilliant.htm",
      "contextRef": "From2023-01-19to2023-01-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 4,
   "tag": {
    "BRLI_OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares, no par value per share"
       }
      }
     },
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://brilliant.com/20230119",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "BRLI_RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights, each right entitling the holder to 1/10 of one Ordinary Share"
       }
      }
     },
     "localname": "RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember",
     "nsuri": "http://brilliant.com/20230119",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "BRLI_UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units, each consisting of one Ordinary Share, one Right and one Redeemable Warrant"
       }
      }
     },
     "localname": "UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember",
     "nsuri": "http://brilliant.com/20230119",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "BRLI_WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each warrant exercisable for one Ordinary Share for $11.50 per share"
       }
      }
     },
     "localname": "WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember",
     "nsuri": "http://brilliant.com/20230119",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brilliant.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-23-005120-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-005120-xbrl.zip
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MD_KV!'@]NO]W<=I.=MK \#]02P,$%     @ ZX$Y5K* 8X1P"0  K6P  !4
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MA07=U&%]Q[@5Q-LP0]R?.)ZHZ.F6C*BJ0_ZN=2O8MX*&Z/_%+?W3):;4+!Q
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MJ(O3YZ3?,:5_,?[,IAA)SG 0)Q9E3RL ET8K4HT<E,/ID]-OG(9,(1$MN17
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M)==<C"$Q?YHN,2?B[]MHL4Q/:2A_DI"(\<<L)E\QYYBFG\AJ1KA6^%=/W0:
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M-2:3.BQ5C5>,&(R!:&1:E(D=$?&O#>8IX?%3)Q0-I6TN *LZ&IK,*SK,WD!
M2KE;1NXXIDDD&[!.2)I2Z],-P&QCZJ'IO.($, =/24J]6U*F2Q+'\AE$3+L;
M%)/8-BVP89V7IM(K8D![(#,J N4A_F!S]B!'YV*8U+.P%;U+>!JVV_@IQ=XB
MI#OL29$*0S+.$4F51Q\[&&HH;=,#6-6YT61>$6/V!K*2R9'2NX?DC(:]$"EU
M;@#1;)KQR$4>PE%WUH6&4+L$XSQ* AQG7L[%-OWV2H?6-B"@71V2AM K4"!W
M("Q90,&,"G$*S'\(YOUPJ2C=P-*P:D:EE'D(BNZM"Q.I=P+)9,-YS37<X\!2
M6YATF2TX@71>@-)AKO$L=R:O@>*H!U(/BCW)=_BN-H9'HLP26VQ Y@HF]/U>
ML "8TAG(9$CJ4"9T4O/%70*:RA<GP>+H,KL$F$W6*:AK/"+!: R@8:=5[[$Z
M(6(B6B:.XPL:DNWOY DL5T-GEPG 9AT*3>01%69G !:Y&"DU$G(G8-SP:"6?
MCHR"CJZB*;2+!F2TSH:N\@@.P!I 1ZY&TXN)RY[D#F\O0@%J-(^R=] [* 'U
M=F'IL%UG!A![A$Z[0X @$83J42Y!NJ !XVM6>=QAPC:B 7R:L! >H71$V86J
M5Q'J:+6&> 18'Y\ 9K70O>R9%,3DVB$J 213<$+<:1B* Y7D_[N,*!F#Y3=J
M[=+58K?.E$'H$4FP.X"?7+E7_$ R!EU37Z Y?$91#]U#<]@7FD.OH3E\"31W
MC\P3:(Z>4=0C]] <]87FR&MHCEX$C:AXIVW-1/R\YG?LT?1P-JAT@DS3JA&8
MG<P_7!K>NF"1 7(\(T-<8J(&5M?\AK.'B ;PD!F2.P$&,&VD1M/ZAX[98!<_
MY8"XB'/:UF2#\LZ3I)"Y:67J)LU-3*;Q#Y*ZL<[&)5.[1.*&)2F._QNM6R?B
M9K$3/(R&C9#4E/ZA8K+7!4P6@T20BXEUCJN\H6%\E4S;;^UNL\E6>8NYNM,+
M"$R.&C>3\ZLGF<AV-4M&.<% BU#?;:V2#:;*.J[L\Z.*FX8:-:S.:Z%Q<2++
M%67CFR6C\ ,"38FMFH;,%;6M[_>BQ@%3>JTK&5(Z1U?CY:J6B;GYKNRSUK/K
M=LJ.O-CA1>WJ;AK==+'?<FU^Y5$J<IZPU6I#\[L\IN<& 9VM6FZU6=2X4>1%
M[;<Y:RP:E&E176P9BRF+HR"2ZR=^$I-/'F%3J4PB6T# !@L:F@HO4 !M-59R
M*86H4%J&X(83"2$1%:%> I2+&?/K^=S8V[>);4'1;;B  U9Z 4FG/1T6$3 ,
M*A$H"T$JQBTV%TFR(?Q9\!A"'"$$F@= :NA]Q DRV0E5%NB2K2D)-J)_?!H?
MSNZBM+$(G5EBK4\"S)4]DK;?"S8 4SH+:I]<S'-\^-?9WU 19;GZK]@=Q_*#
M-=.GU8S%P.I31I4M"%HL%AP8)%Z@ /O2:;AB*)>B3.MB=:J:64-QM/VV ##:
M*JJ^MM.+2C<Y:IS\M;IVU.2?;8.E,$6 %Q+,,MM-O\FDWOQ7-5X@T&*L,2G)
MI:C0NG@A8==E+;H' 0MG@X!%QR!@X>,@8-%W$+!P-@@HLLV6")&?D9C%T0(#
MBQ.VJFU#T6)9Y\,@]0H5V!_89I0A:!=C>T5+M<29_"0@7ZG\S\4/0RD!G;4U
M+=MLEHM:FD1>,-+FK+&L9;;H7$6,I-HV%YLP2DF8F3F/**9!A.-R>433%?'N
M$&NT]#1?@M.A]X.A?B8;.&5AQ5J&9>!NJ4O;E]*S!S"^DCC^G;)'.B4X892$
MV;44TYVB=KW=)V8Z;-<?F@'$7N#4QR'PZ(P,&M[+*%2$Y5?"G)#TA<4;FF*N
MWB7GII8)T-DE![!9)T83>42*V1E 2"E&F=K-"]K9ZA'E("O[UC%80$AN^77M
M5M/:6]M&K4?,M!J$WN'.U_S8C8VS*$>O6*:$XR"-'LA'G.+<&UA>2&[[I<HV
MT_K;E":M1PBU&@3?GRQCY%(QN&#*V9(Q?"*&6@O6\I2XIK*_<$S#8G/MF%+B
M$1XF7RTKR'!4:)VP,%WA./ZP22)*$K@CTE1V63!:K+-0DWC$@LD7P(*2HD+K
MA(6S%>$+T;W]QMECNLS79P7+!JCMLM%JN<Z(4>H1*VW^ &:*$)3%%$OJNH%G
MNUM0/%ME$2ZI06H9&]"LQDQ#YQ,PD+D&+3$)Y/66*Y:B.X8^)T1]!%0]SAJ*
M[965X+-T7'UI) CD"Q'9J)R&F)L0:A-;_^H(:+CQ[9&&T@N0.NW!WR$I(U 1
M8IF::\$PK\[CE GY+3WP;8?N$%L$]35?<-2E]X*FGB8;W]^68?7)M0I4WT5T
MN9I1=7%[>(A7$UD>&1L,:@/CBL(+1D!;T+"X^JT -VOG;69Q%)S'#,-766H:
MRROF->UIB^7M!!X1T'0%+9&GA$@IG=3_!TSO^6:=!D\WG 6$R*>LDK*UZKK^
MUC/:+C//*E*=IEZA'G'V'+\ @;LD4"6-O4J/Y?)BGGQH7*[FQH)[]5GRY'J3
M)K('%<;@J^"M099O+_0H@':3H27"(_1ZV(1N.*A(I$+WLJ_-)Z@2[6A^ENQ6
M 23AAZ=;,B=<OG=P1[;I!Y'1?<L,HT>L[=E;[^+HD[G.0"\@?*Y;:*J7H&H"
M:":?$<N30-]D(DBE8OI^>773I?@E-A>;Q#\SG!"QY?]02P,$%     @ ZX$Y
M5O[$N\>R"   /V<  !4   !B<FQI+3(P,C,P,3$Y7W!R92YX;6S575USVS86
M?>_,_@=5^RSKP\UV[<;;L16KJZD3N9:3M/N2@4A(PA@$- !I2_]^ 7XHDDB
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M>8X+^OC,U%VGH8ZF8$ XNN."2](==TW:M<$[4>TE$Z;PNZ=/IF[%U/!/4"1
M.$.#?E5ML&?=$\K)\B>M6[ 4=(*R*?1"O-( F,7<T$>Z@)5H(,E-[HX)^_2P
M[P+6\?N:H3I.=]QWK=%%9:$[J2.T8PXWAZEWN42@PA/*)<_HKR31"(*=CG6J
MVE]4PZ.GU&:/_@[RNQ\67DGK0:3%>)4Q-?N+J5U0=I,/E@%VV\!2E/PJC_\=
M]/8$U+P2X8.(4.@&AFOQ=V-![9'NH.9H6G8<R_!(4;*E_-\E #>$IE?B//3
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M2Z"18C,C3]-Y0<,T"OD?=!3DVW#-$7PB#(>QA\5N>(F:4+1GJ*)^P"(L8K.
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M+ Z>3KP!XYZ'J@J?PB]I-("&">M!%U@,,Y#&&7]#UV%VPWN1O#%,JUB$+(Q
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MCQ8:.56'3$6%C=7$11@3-3&WZ#1SE-Z.&*B4KB)CN* @[,EU#CN;ZR!S*[X
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MA%QXA5J;8\+<[,!X@?V9CQ=,$?DF.;Y_V:Q^03.R?]WY>'/Q_U!+ P04
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M>1N/#D!$*?3V-H"5<]:VK&=PHC5X3\E?<.I -Q"<>3-7URTUE"5U@FD/S46
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MJUUBYUQ(YWP50=A8]1*4N=F?C$<4CF684#-[17%"U^G-I2K$_7-C,I!,)B=
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M-XDOQ^[H^W7/HHR#O3]4]?59];Y:\.3@S;NC@Y/]L\/CH^CX533 8V]YU6Z
MCRWTHLYL?8OT>%'&U9D[A>L!34Y+"_- </V*71-R18=ZG40KJ?G& )XR1N:
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M4N-F]^##WMGTWNE+>/?Q+N[-V&80V6R0G%W?X[V3>KLU<-'XLG4C_]M&Y^W
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MP0/"&<Z=%^:<<M5K=%#C-YTJ",.][_7RJ\%6OT^AZF.0/KGM8D<H@&6I9R"
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M&E=%,)8BYVT\HO*!!1HY>S\F-H7)OSN5, 7,?Z83@K6?XSDS0TPVXLYYLFP
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M86YT+FAT;5!+ 0(4 Q0    ( .N!.5930TG4F!8  +"8   <
M  "  =Q0  !E83$W,C$Y,F5X,3 M,5]B<FEL;&EA;G0N:'1M4$L! A0#%
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(  !(U      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
